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Abstract 
The global antibiotic resistance crisis is a growing issue which poses a significant threat to human 
and animal health, and will limit the effectiveness of infection treatment in clinical settings. 
Traditionally research efforts have concentrated on discovering novel antibiotics, however an 
alternative approach is being utilised which focuses on the control and removal of antibiotic 
resistance from the environment. A major source of environmental antibiotic resistance originates 
from the release of treated waste water effluent (WWE) from local waste water treatment plants 
(WWTP) into natural aquatic environments, such as canals and rivers. Study has shown released 
WWE contains high numbers of antibiotic resistant bacteria and residual active antibiotics. In 
particular members of the Enterobacteriaceae family expressing extended spectrum beta-
lactamases (ESBLs), such as the highly prevalent CTX-M group 1 genes, have been commonly 
identified in WWE and have been shown to be more prevalent in natural aquatic environments 
following the addition of WWE. These ESBL genes are commonly plasmid borne, and their 
prevalence has been attributed to their ability to be rapidly disseminated by horizontal gene 
transfer. Once spread through the bacterial population, antibiotic resistance plasmids are 
maintained by the selective pressure of high levels of antibiotics, introduced to the environment by 
WWE. This study aimed to identify the effect of WWE addition on the ESBL expressing Escherichia 
coli (ESBLEC) population of natural aquatic environments, and the genetic elements found on 
plasmids extracted from ESBLEC isolates. ESBLEC were isolated from the Sincil Dike, Lincoln, UK 
upstream, at the point of and downstream of WWE release. Plasmid DNA was then extracted from 
these isolates and the genetic elements they contained identified by PCR, CTX-M group 1, 3 
addiction systems (Hok-Sok, PemK and ccdAB) and 3 incompatibility groups (IncF, IncN and IncP) 
were detected. This data was arranged into unique plasmid genotypes which were used to 
determine the effect of WWE addition on the individual genetic elements identified, and on the 
ESBLEC plasmid population as a whole. It was found that the number of ESBLEC isolated increased at 
sample sites that had received WWE and was attributed to the influx of ESBLEC producing organisms 
previously identified in WWE. Further genetic analysis revealed that the increase in the number of 
ESBLEC was accompanied by a shift from a few dominant plasmid types to a larger number of 
genetically diverse plasmids. This diversification event appeared to favour IncF plasmids containing 
alternate ESBL genes and multiple addiction systems, which allowed their persistence downstream 
while competing with naturally occurring genotypes. Overall it is clear that the addition of WWE to 
natural aquatic environments has a measurable impact on the number of ESBLEC and the plasmid 
genotype they contain. This may have a significant effect on the transfer and maintenance of 
antibiotic resistance in the environment. A larger study which detects a wider range of plasmid 
genetic elements across a larger number of sample sites would allow for a deeper insight into the 
effects of WWE release on plasmid containing ESBLEC in the environment. 
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Chapter 1 - Introduction 
1.1 Antibiotics 
1.1.1 The Antibiotic Revolution 
Antibiotics can be broadly defined as chemical agents, often of natural origin, which possess the 
ability to destroy or inhibit the growth of a microorganism (Waksman, 1947).  In 1909 the Nobel 
laureate Paul Ehrlich observed that synthetic dyes used at the time stained only specific organisms. 
This led to the idea of a “magic bullet”, a compound which could exert its full antimicrobial action on 
the target with no effect to the host. Using this principle Ehrlich began a mass screening effort to 
discover an antimicrobial compound effective against the sexually transmitted infection syphilis, 
caused by the bacteria Treponema pallidium. This drive resulted in the discovery of a compound 
known as Salvarsan, an effective treatment for syphilis with far less associated side effects than the 
popular treatment of organic mercury (Fitzgerald, 1911; Aminov, 2010).  
Following the success of Ehrlich, in 1929 Alexander Fleming made the next leap in antibiotic 
development by discovering the antimicrobial properties of the fungus Penicillium chrysogenum, 
from which the active ingredient of penicillin was purified. This new antibiotic was used to treat 
infections which previously would have been fatal, however the low activity and narrow spectrum of 
penicillin, then only available orally, meant it was not suitable to treat the majority of clinical 
infections. Research efforts turned to the modification of penicillin to create a more effective 
antibiotic active against a wider range of bacteria, kick starting the antibiotic revolution (Fleming, 
1929; Acred et al. 1962).  
During the mid-20th century research efforts were rewarded with the production of modified 
penicillins which became available for clinical use to treat previously fatal infections, such as 
pneumococcal pneumonia (Aldridge, 1999). These were widely used due to their low toxicity and 
high efficacy; the result of targeting only the components of prokaryotic cells, leaving host 
eukaryotic cells unaffected. Antibiotics were also easy to produce due to their natural fungal source 
which could be cultured effectively in vitro (Aminov, 2010). In the 20 years following the discovery of 
penicillin, prontosil, streptomycin, erythromycin and tetracycline were discovered and implemented 
for use as broad-spectrum antibiotics to treat a variety of infections, many of these are still used 
today (Lewis, 2013).  
However, a multitude of factors has led to the abuse of virtually all of our antibiotics, complacency in 
prescribing combined with a lack of understanding by patients has led to their inappropriate use in 
millions of cases. A significant factor in the overuse of antibiotics came in America during the 1950s, 
when antibiotics were approved for the use as a growth promoter in cattle, a trend which quickly 
spread to commercial agriculture around the world (Gustafson and Bowen, 1997; Gross and Patel, 
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2007). This resulted in an inevitable decrease in their effectiveness due to overexposure and the 
eventual development of resistance by the target bacteria. In the same decade they were approved 
for agricultural use, tetracycline, methicillin, penicillin and erythromycin resistance was discovered in 
naturally occurring bacterial strains for the first time (Lewis, 2013).  
In the years since antibiotic resistance first emerged, science has been engaged in a race to develop 
new antibiotics and slow the spread of resistance in an effort to prevent modern medicine returning 
to a pre-antibiotic era. Despite these efforts government bodies have been slow to react to this 
developing crisis, with the use of antibiotics as a growth promoter and their inappropriate use 
clinically still a major issue today.  
1.1.2 Types of Antibiotic 
As work on antibiotic modification progressed, many related antibiotics were produced for clinical 
use, which can be grouped by their method of bacterial inhibition or class. There are two main types 
of bacterial inhibition, bacteriostatic and bactericidal. Bacteriostatic antibiotics prevent cell 
replication and halt cell growth to lower the bacterial population within the host, allowing host 
defences to effectively mobilise and remove the infection. Bactericidal antibiotics act to induce rapid 
cell death to remove an infection without the use of host defences, typically by inhibiting ribosomal 
function (Weisblum and Davies, 1968; Pankey and Sabath, 2004; Kohanski et al. 2007). Table 1 
shows the cellular targets and method of inhibition for some commonly used antibiotics.   
Antibiotic(s) Bacteriostati
c/Bactericida
l 
Method of bacterial 
inhibition 
Cellular Target 
Tetracycline Bacteriostatic Halt cell metabolism 30s Ribosome (Kohanski et al. 
2007) 
Macrolide 
Family 
Bacteriostatic Halt cell metabolism 50s Ribosome (Kohanski et al. 
2007) 
Beta-Lactam Bactericidal Inhibit cell wall 
synthesis 
DD-transpeptidase (Tomasz, 
1979) 
Quinolone 
Family 
Bactericidal Inhibit DNA synthesis DNA Gyrase (Drlica and Zhao, 
1997) 
Table 1. Examples of commonly used antibiotics, their mode of action, method of inhibition and 
cellular target 
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As most newly implemented antibiotics are modifications of existing antibiotics they can also be 
grouped based on their common origin, known as a class. The main class of antibiotic used in this 
study are cephalosporins derived from the fungus Acremonium spp., modification of which led to 
several new generations of antibiotic with slightly different properties to the previous generation. 
This structural change resulted in an increase in the spectrum of activity and reduction of resistance 
when used clinically (Jen et al. 1972; Perez-Inestrosa et al. 2005). Currently the third generation 
cephalosporins ceftriaxone, cefoperazone and cefotaxime are commonly used cephalosporins and 
are being utilised to treat a variety of infections, however resistance to these third generation 
antibiotics is rapidly growing (Davies, 2011; Bush, 2016; Goudanavar et al. 2016).  
1.1.2.1 Beta-lactam Antibiotics  
The cephalosporins belong to a further class of antibiotic with the penicillins, carbapenems and 
monobactams known as the beta-lactams, which all share a basic core structure of a nucleated beta 
lactam ring. Penicillin and all its derivatives contain a 6-aminopenicillanic acid (6-APA) side chain 
(Figure 1A) (Sheehan and Logan, 1959) while cephalosporin derivatives contain a 7- aminopenicillic 
acid (7-APA) side chain (Figure1B) (Nagarajan et al. 1971), this small change of nucleus location leads 
to a different class of antibiotic with a different spectrum of activity. Newer generations of beta-
lactams have been developed by modifying this side chain to increase effectiveness or reduce 
resistance in the target organism.  
 
 
 
Figure 1.  Structure of the lactam ring found at the centre of beta-lactam antibiotics, and the 
differing location of the aminopenicillic acid side chain (Kong et al. 2010) 
 
 
Beta-lactams are bactericidal antibiotics that interfere with transpeptidase enzymes within the 
bacterial cell wall to prevent adequate linkage of the peptidoglycan subunits, inhibiting cell wall 
synthesis and inducing cell death (Wilke et al. 2005; Dorr et al. 2016). As human cells do not contain 
4 
 
an analogue of transpeptidase, beta-lactam antibiotics have a very low associated toxicity and a 
wide spectrum of activity. Their use is indicated against both Gram positive and Gram negative 
organisms, and in a range of infections such as urinary tract infection, soft tissue infection and as a 
prophylaxis to prevent infective endocarditis (Holten, 2000; Etebu and Arikekpar, 2016). The 
desirable properties of these antibiotics has led to an explosion in their use clinically, however their 
abundance has driven selective pressure for organisms which express resistance. The most 
significant mechanism of resistance to beta-lactams is the presence of the beta-lactamase enzyme 
which hydrolyses the beta lactam ring at the centre of beta-lactam antibiotics, rendering them 
inactive (Shaikh et al. 2015).  
1.2 The Antibiotic Resistance Crisis 
1.2.1 The Overuse of Antibiotics 
The use of antibiotics has rapidly grown in the years since their introduction, forming a vital tool in 
the treatment of clinical infection. In theory, antibiotics should only be prescribed for bacterial 
infections which cannot be resolved by the host immune system, using an appropriate antibiotic at 
an appropriate therapeutic dose. However, in clinical practice antibiotics are used in bacterial 
infections that may have otherwise resolved naturally, or for infections that have not been 
confirmed as bacterial.  
 
This has been supported by recommendations on antibiotic stewardship from the National Institute 
for Health and Care Excellence (NICE), which state that before prescribing antibiotic treatment, a 
physician should consider whether pharmaceutical intervention is necessary to improve the patients’ 
prognosis, and prescribing antibiotics should be avoided where possible (NICE, 2015). This is in line 
with earlier recommendations made by the Infectious Disease Society of America (IDSA), which 
stated that antibiotic treatment is not appropriate in cases of asymptomatic bacteriuria, even when 
pyuria is observed (Nicolle et al. 2005). This is further supported by the American Academy of 
Otolaryngology who recommended antibiotic use in adult bacterial sinusitis only when complicating 
factors were present, such as upper respiratory infection, and when a bacterial cause can be 
identified in laboratory testing (Rosenfeld et al. 2007). The frequency of these recommendations 
suggest inappropriate antibiotic prescription is still a significant issue in the clinical setting. 
 
Between 2000 and 2010 global antibiotic use grew by 30% increasing from 50 to 70 billion doses, 30 
billion of which were prescribed in just 3 countries: India (13 Billion), China (10 Billion) and the 
United States (7 Billion) (CCDE, 2015). It is estimated that 60% of globally prescribed antibiotics were 
penicillin or carbapenem derivatives, with the number of prescribed last resort antibiotics, those 
used as a last line of defence such as colistin, increasing by 53% (Van Boeckel et al. 2014).  
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Many of these antibiotics were used appropriately however a large number were prescribed 
unnecessarily. It is estimated that antibiotics are misused in 30-50% of cases and a pathogen 
identified in only 7.6% of cases in the United States (Van Boeckel et al. 2014). Improper prescription 
could be due to the low toxicity and cost of most antibiotics making them practical to prescribe even 
when a firm diagnosis cannot be reached. A lack of patient understanding between bacterial and 
viral infection can also lead to pressure on physicians to prescribe antibiotics even when 
unnecessary, or the discontinuation of an antibiotic regime by the patient due to the alleviation of 
symptoms. These phenomena lead to an excess of antibiotics in the environment and their 
overexposure to clinically relevant organisms, placing selective pressure on resistant strains and 
allowing their proliferation (Ventola, 2015; Ashraf and Cook, 2016).  
 
Furthermore, in some countries antibiotics are still used in large quantities in agriculture as a growth 
promoter. It has been long understood that by adding antibiotic supplement to animal feed it is 
possible to increase the meat yield and health of the animal, with 80% of antibiotics used in an 
agricultural application. This overexposure acts by the same mechanism as over prescription, 
however resistant organisms in animal microbiomes are able to enter the human food chain via 
detectable levels of resistant bacteria in meat and agricultural land. Waste from these sources can 
run off into aquatic or natural environments and result in exposure to other human and animal hosts 
(Bartlett et al. 2013; Frère and Rigali, 2016; Tasho and Cho, 2016).  
 
Around the world there is a call for the restriction of antibiotic use, both in clinical and agricultural 
settings. However, statistics on global antibiotic use make it clear that even when governments have 
adopted policies on the restriction of these vital medicines, they have been too slow to act, while 
other nations are yet to recognise the threat of antibiotic overuse and continue to use antibiotics in 
an unsustainable way.  
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1.2.2 The Rising Incidence of Antibiotic Resistance 
 
Since the recognition of growing antibiotic resistance, a global effort has been coordinated to 
prevent the end of the antibiotic era. Strategies focus on global monitoring schemes to measure and 
track the incidence of antibiotic resistance, and safeguarding vital last-resort antibiotics by 
regulating their use.  
 
Methicillin resistant Staphylococcus aureus (MRSA) is one of the most well-known infection causing 
resistant bacteria in a clinical setting, and is often dubbed a ‘Superbug’ in the media due to its 
prolific spread and high associated mortality rate. Incidence of MRSA has been declining in many 
Western countries in the last decade due to better antibiotic regulation, in the UK incidence of 
MRSA fell by 84.7% between 2003 and 2011 and was only responsible for 1.6% of bacteraemias 
(Davies, 2011; Ventola, 2015). Other countries have responded less well to the call for antibiotic 
control and still have a significant MRSA issue. Sub-Saharan Africa, Latin America, India and Australia 
all have a rising incidence of MRSA infection with Latin America experiencing a resistance rate of up 
to 90% (CCDE, 2015). 
 
Carbapenem-resistant Enterobacteriaceae (CRE) are defined by resistance to all last-resort 
carbapenems effective against Gram negative bacteria and are responsible for a significant number 
of infection associated mortalities. Escherichia coli and Klebsiella pneumoniae species are most likely 
to show resistance with an approximate 10-13% incidence in Europe, the United States and Asia, and 
a much higher incidence of 28% in parts of Latin America (CCDE, 2015).  A systematic review of 
global CRE and carbapenem-susceptible Enterobacteriaceae (CSE) infection, comprising 20 studies 
reporting on 692 patients found that CRE was twice as likely to be fatal when compared to CSE. 
However, several methodology flaws were identified in these studies, including non-randomisation 
and a focus on critically ill ICU patients who would be less able to recover from any infection 
regardless of its resistance profile. It was also noted that combination antimicrobial therapy had a 
lower associated mortality rate than monotherapy, and that carbapenems prescribed with a last 
resort antibiotic colistin conferred a more favourable outcome (Falagas et al. 2014).  
 
This increasing incidence of antibiotic resistant infection in the clinical setting not only has a human 
cost, but also a calculable economic cost. A review on the cost of antimicrobial resistance 
commissioned by the UK government in 2014 found that by 2050 antibiotic resistance will cause an 
estimated 10 million deaths per year with a 2-3.5% reduction in gross domestic product (GDP), 
costing $100 trillion globally (Oneill, 2014). To reverse the antibiotic resistance crisis, current efforts 
to regulate antibiotic use and promote research into novel antibiotics must be continued. However, 
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a focus on innovative solutions to remove antibiotic resistance from the environment and prevent its 
spread should also be implemented alongside current efforts.  
 
1.2.3 Mechanisms of Antibiotic Resistance 
 
In the 1940s antibiotics began to be utilised to treat serious infection among wounded World War II 
soldiers, resulting in the mass production of penicillin. Alexander Fleming himself identified the use 
of penicillin in the second Great War as a contributing factor to the increase in antibiotic research 
and development in his 1945 Nobel Prize speech. However, shortly after his discovery Fleming noted 
the emergence of penicillin resistance, and by the 1950s this had become a significant clinical issue 
which threatened to undo much of the progress made in the treatment of bacterial infection in the 
previous decade (Ventola, 2015; Fleming et al. 2016).  
 
Overexposure of bacteria to antibiotics can lead to the development of protective systems in the 
target organism by natural selection. Bacterial strains able to survive in the presence of antibiotics 
are allowed to replicate and transfer these resistance mechanisms to the next generation of 
organism, while non-resistant organisms are eliminated from the environment. The three main 
mechanisms of antibiotic resistance are: alteration in cell wall permeability, degradation or 
modification of active antibiotics and alteration of target proteins (Hoffman, 2001; Munita and Arias, 
2016). 
 
In order to have an antimicrobial effect, all antibiotics regardless of mechanism of action must first 
cross the cell membrane in order to reach its cellular target. To prevent this, some bacteria are able 
to modify the cell wall membrane to prevent certain antibiotics from entering the cytoplasm (Frost, 
2007; Blair et al. 2015). This can involve thickening of the cell wall to prevent diffusion into the cell 
cytoplasm, as observed in resistance of Staphylococcus aureus to vancomycin (Cui et al. 2003). 
Antibiotic that has crossed the cell membrane can also be removed back to the extracellular 
environment by the expression of efflux pumps, as observed in erythromycin resistance of E. coli (Li 
et al. 2015). 
 
If an antibiotic is able to cross the cell membrane and enter the cytoplasm, it may still be subject to 
degradation or modification by a variety of enzymes (Debabov, 2013). Antibiotic degradation occurs 
in a number of bacterial strains and is typically mediated by hydrolysis of the ester or amide bonds 
which are central to the biological activity of most antibiotic compounds, rendering them inactive. 
Beta lactamase is the most prevalent degradative enzyme, which inactivates beta-lactam antibiotics 
such as penicillins and cephalosporins by cleavage of the beta-lactam ring central to the antibiotic 
structure. Antibiotics can also be modified by enzymes present in the cytoplasm, rendering them 
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inactive without breakdown of their original molecular structure. This process is usually mediated by 
transferase enzymes which attach a co-substrate such as ATP, acetyl-CoA or glutathione to the 
antibiotic structure, altering its ability to bind to the target site (Wright, 2005; Blair et al. 2015).   
 
Some classes of antibiotic have protein targets necessary for cell growth and metabolism, such as 
ribosomal sub units or DNA replication machinery. By interfering with these vital proteins, cell 
growth can be slowed or even halted completely. Target organisms can spontaneously develop 
mutations in these proteins resulting in structural changes which allow the cell to carry out normal 
metabolic function, but can no longer be affected by the antibiotic. These organisms are positively 
selected over non-mutated organisms in antibiotic rich environments, facilitating their proliferation. 
Mutation of DNA gyrase can result in protection from quinolones, while mutation of RNA 
polymerase induces resistance to rifamycins (Lambert, 2005; Frost, 2007; Blair et al. 2015).  
 
By further understanding the mechanisms responsible for antibiotic resistance, future research 
efforts can focus on the removal or interference of the biochemical processes responsible for the 
development of bacterial protective systems. This could result in the return of many antibiotics to 
therapeutic use which are currently ineffective due to widespread resistance.  
 
1.2.3.1 Extended Spectrum Beta-Lactamases  
 
Extended spectrum beta-lactamases (ESBLs) are a class of beta-lactamase enzyme responsible for 
the hydrolysis and inactivation of a wide range of beta-lactam antibiotics (Shaikh et al. 2015). ESBLs 
offer antibiotic resistance against all beta lactam antibiotics, except the broad spectrum 
carbapenems and the cephalosporin-like cephamycins, however resistance to these last line 
antibiotics is growing (Papp-Wallace et al. 2011; Korzeniewska and Harnisz, 2013).  
  
ESBLs first emerged in Western Europe following inappropriate clinical use of extend spectrum beta-
lactam antibiotics, but quickly spread to the United States and Asia. ESBL production is most 
commonly seen in clinical E. coli and K. pneumoniae isolates, where it is associated with an increased 
treatment failure rate (Pitout et al. 2005; Shaikh et al. 2015). 
  
Beta-lactamase inhibitors such as clavulanic acid can be combined with beta-lactam antibiotics and 
effectively used on otherwise resistant ESBL producing organisms. These inhibitors share structural 
homology with penicillin antibiotics and contain a beta lactam ring, but show little or no 
antimicrobial properties alone. This similarity in structure allows beta lactamase inhibitors to 
reversibly bind to the ESBL enzyme, however upon cleavage of the beta lactam ring an acyl group 
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remains permanently covalently bonded within the enzyme active site, rendering it inactive (Buynak, 
2006; Drawz and Bonomo, 2010).   
ESBL genes were originally located on the bacterial chromosome, but have been recombined onto 
bacterial plasmids where they are easily spread through bacterial populations of different species. 
There are three main types of ESBL gene, SHV, TEM and CTX-M.  TEM is the most prevalent ESBL 
type containing over 90 subtypes, with TEM-1 the most common in Gram negative bacteria, causing 
over 90% of ampicillin resistance in E. coli. TEM-1 is effective against penicillins, however selective 
pressure from the inappropriate use of beta-lactam antibiotics has resulted in the emergence of 
TEM types which are effective against extended spectrum beta lactam antibiotics, such as TEM-3 
and TEM-12  (Livermore, 1995; Shaikh et al. 2015). There are few SHV subtypes with SHV-1 most 
prevalent, causing up to 20% of plasmid mediated resistance in K. pneumoniae isolates (Tzouvelekis 
and Bonomo, 1999). These enzymes show activity against broad spectrum penicillins but little 
activity against cephalosporins (Shaikh et al. 2015).  CTX-M enzymes have emerged within the 21st 
century and show little structural or spectrum homology with other ESBL enzymes and contains 
several subtypes. CTX-M enzymes preferentially hydrolyse cefotaxime and are commonly found in 
Enterobacteriaceae such as E. coli. (Tzouvelekis et al. 2000). 
1.2.3.1.1 CTX-M gene 
 
The CTX-M genes encode a class of ESBL enzymes with action against ceftazidime and cefotaxime. 
The CTX-M family are the most widely disseminated ESBL enzyme type and are typically plasmid 
mediated and common in Enterobacteriaceae species, however recombination to the chromosome 
can occur.  
 
The CTX-M family can be separated into different groups based on the similarity in amino acid 
sequence, genes containing over 94% similarity are classified in the same group while genes sharing 
less than 90% similarity are placed into distant groups. There are 5 distinct CTX-M groups when 
classified this way, containing 40 different enzymes in total, in particular the CTX-M group 1 enzyme 
CTX-M-15 is rapidly spreading and is often implicated in nosocomial infection (Table 2) (Boyd et al. 
2004; Castanheira et al. 2014). Table 2 shows the 5 CTX-M groups and the common specific CTX-M 
types they contain (Bonnet, 2004; D'Andrea et al. 2013 ). A more recent classification system used 
the alignment of amino acid sequences to arrange CTX-M genes into 7 clusters of varying 
relatedness.  Figure 2 shows these clusters and Table 3 shows the number of genes and percentage 
identity of each cluster (Zhao & Hu, 2013).  
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CTX-M group Specific CTX-M types contained 
CTX-M group1 CTX-M-1, -3, -10, -12, -15, -22, -23 
CTX-M group 2 CTX-M-2, -4, -5, -6, -7, -20, -76, -77 
CTX-M group 8 CTX-M-8, -40, -63 
CTX-M group 9 CTX-M-9, -14, -15, -16, -17, -18, -19 
CTX-M group 25 CTX-M-25, -26, -39, -41, -91 
Table 2. The 5 CTX-M groups and the specific subtypes they contain (Bonnet, 2004). 
 
 
CTX-M Cluster Number of CTX-M genes 
contained 
% identity of group members  
CTX-M-3 Cluster 42 97.6-99.7% 
CTX-M-14 
Cluster 
38 97.3-99.7% 
CTX-M-2 Cluster 16 95.2-99.7% 
CTX-M-25 
Cluster 
7 98.6-99.7% 
CTX-M-8 Cluster 3 97.9-99.7% 
CTX-M-64 
Cluster 
2 95.9% 
CTX-M-45 
Cluster 
1 N/A 
 
Table 3. The 7 CTX-M clusters, the number of genes they contain and their % identity (Zhao & Hu, 
2013).  
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Figure 2. Phylogenic tree of the 7 CTX-M clusters (Zhao & Hu, 2013). 
 
In Western Europe the CTX-M gene was first identified in Germany in 1989 but rapidly spread 
around the continent (Bauernfeind, A et al. 1990). In 2000 CTX-M was first detected in the UK and 
between July 2001 and February 2002 when an outbreak of CTX-M producing K. pneumoniae was 
identified(Alobwede et al. 2003; Brenwald et al. 2003). In addition to implications in clinical 
infection, CTX-M has also been detected in healthy human and animals which may serve as a 
reservoir, and study of UK waterways has revealed large reservoirs of CTX-M genes, including the 
first environmental instance of CTX-M-15 in the UK (Hawkey and Jones, 2009; Amos et al. 2014). The 
overuse of ceftriaxone and cefotaxime clinically may be the cause of CTX-M emergence and its 
maintenance in a widespread multi-locational reservoir (Alobwede et al. 2003).  
  
Bacterial strains containing a member of the CTX-M family show a wide range of minimum inhibitory 
concentration (MIC) due to variation in CTX-M groups and other host genetics (Bonnet, 2004). In 
practice resistance to cefpodoxime is used as a phenotypic marker of CTX-M expression, however 
some CTX-M expressors are susceptible to cefpodoxime and therefore should be used in 
combination with an ESBL inhibitor such as clavulanic acid (EUCAST, 2015).  
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1.3 Mobile Genetic Elements 
 
1.3.1 Overview of Bacterial Mobile Genetic Elements 
 
Mobile genetic elements are sections of DNA that can move within a bacterial genome and be 
transferred between bacteria with genetic homology. Mobile genetic elements can contain a wide 
variety of genes, but most commonly contain virulence factors such as exotoxins or resistance genes 
which provide increased survivability and transferability in the expressing organism. There are many 
types of mobile genetic elements, but the most common are plasmids, transposons and gene 
cassettes.  
 
Plasmids are a circular transferrable genetic elements that require a bacterial host for survival and 
contain a variety of genes, including resistance genes, addiction system genes, replication genes and 
genes responsible for segregationally stability. Typically, plasmids function to provide increased 
survivability or proliferation to their host organism, ensuring host survival and continued plasmid 
replication and dissemination. Resistance genes are commonly plasmid borne and are expressed by 
host machinery to provide protection from toxins within the environment, such as antibiotics or 
heavy metals. This protection results in the positive selection of bacterial cells containing expressible 
plasmids, resulting in a greater plasmid prevalence among the surviving bacterial population 
(Carattoli, 2009). 
 
Transposons are single stranded sections of DNA that can mobilise themselves from bacterial 
chromosomal DNA into the cell cytoplasm. Once mobilised transposons can re-enter the 
chromosome at a different location causing mutation which can lead to the spontaneous generation 
of antibiotic resistance. Transposons, often coding antibiotic resistance genes, can also relocate to a 
plasmid within the cell cytoplasm which can then be transferred within the bacterial population and 
then recombine back to a bacterial chromosome, these are known as insertion sequences and 
require the host genome to translate the DNA sequence (Bennett, 2008; Siguier et al. 2014)  
 
Much like a transposons, gene cassettes are mobile genetic elements which often contain antibiotic 
resistance genes which can relocate within a bacterial chromosome, or be transferred within the 
population by horizontal gene transfer. Gene cassettes also carry specific recombination sites, these 
are lengths of DNA responsible for the re-insertion of the gene cassette into a host chromosome. A 
gene cassette can only be inserted into a chromosome where its complimentary recombination site 
is present, this makes gene cassettes a useful tool in genetic engineering where a single gene needs 
to be inserted at a specific chromosomal location (Hall & Collis, 1995; Hall et al. 1996; Bennett 1999).  
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1.3.2 Plasmids 
 
1.3.2.1 Definition, Function and Structure 
 
As mentioned previously, plasmids are a circular transferrable genetic element that often contain 
antibiotic resistance genes and can disseminate throughout a bacterial population. In 
Enterobacteriaceae, plasmids carrying ESBL resistance genes are common, such as the bla gene 
family which encode SHV, TEM and CTX-M type enzymes (Carattoli, 2009).  
 
As well as increased survival, increased dissemination can be provided by plasmids carrying virulence 
genes. Once expressed in an organism, these genes are able to induce a pathogenic phenotype in 
previously commensal bacterial strains, resulting in increased transmission and replication of the 
pathogen which in turn increases the number of plasmid copies present in the environment. In E. 
coli, virulence plasmids are responsible for the formation of several pathogenic strains, Table 4 
shows the common intestinal pathogenic E. coli strains associated with virulence plasmids and their 
symptoms (Johnson and Nolan, 2009).   
 
 
Virulence plasmid associated E.coli  Strain Common associated symptoms 
Enterotoxigenic E. coli (ETEC) Watery diarrhoea 
Enteroinvasive E. coli (EIEC) Watery diarrhoea, Inflammatory colitis, Dysentery  
Enteropathogenic E. coli (EPEC) Non-bloody diarrhoea 
Enterohemorrhagic E. coli (EHEC) Non-bloody diarrhoea, Haemorrhagic colitis, 
Haemolytic-uremic syndrome 
Enteroaggrevative E. coli (EAEC) Persistent diarrhoea 
Extraintestinal pathogenic E. coli (ExPEC) UTI, Sepsis, Neonatal meningitis 
Table 4. The 6 types of pathogenic E. coli caused by plasmid virulence genes and the 
commonly associated symptoms in human infection (Johnson and Nolan, 2009).   
 
Structurally, plasmids consist of double stranded DNA in a circular structure which can exist in 
different conformations. In vivo plasmids are found in a supercoiled conformation with the circular 
structure twisted to introduce tension, decreasing its physical size. During replication of some 
plasmids a cut is made in a single strand of the closed circular DNA to release the tension from the 
supercoiled structure, known as nicked relaxed circular, while two cuts at the same point on both 
strands results in a linear plasmid. (Prazeres, 2011).  
 
1.3.2.2 Methods of Transfer 
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Plasmids can be transferred vertically to daughter cells during replication or by horizontal gene 
transfer by three main methods: conjugation, transformation and transduction.  
 
Conjugation is the exchange of genetic material between bacteria by direct cell to cell contact 
through attachment of a sex pilus. In E. coli, cells containing a plasmid that confers resistance, such 
as the broad-host- range RK2 plasmid, are known as R+ cells, which express sex pilus on the cell 
surface and initially attach by cell-to-cell contact to a recipient cell. A nick is made in the donor 
plasmid allowing relaxation from its supercoiled conformation, and a single strand is transferred to 
the recipient R- cell which does not express a sex pilus. Both cells synthesise a complementary strand 
to the single stranded DNA to form a double stranded circular plasmid, the R- cell is now an R+ cell 
and is capable of initiating conjugation. Through this method plasmid associated antibiotic resistance 
genes are readily spread throughout the environment. (Figurski et al. 1982; Griffiths et al. 2000).  
 
Exogenous plasmid DNA can be found in bacterial environments following the lysis of plasmid 
containing cells, this DNA can be taken up by bacterial cells during transformation. Exogenous single 
stranded plasmid DNA first adheres to cell surface receptors of competent cells, those which express 
the required receptors and transport systems to internalise exogenous DNA. Single stranded plasmid 
DNA is then transported across the cell membrane by DNA translocase, where a complementary 
strand is synthesised. This plasmid DNA can then be recombined into the host chromosome or 
remain in the cell as a fully formed plasmid (Lorenz and Wackernagel, 1994).  
  
During transduction bacterial viruses known as phage attach to the bacterial cell wall and establish 
metabolic control. Phage DNA is then injected into cell cytoplasm to hijack cellular machinery and 
create new virus DNA, which is packaged and assembled into a new virus particle and released upon 
cell lysis. During this process plasmid DNA can inadvertently be replicated and packaged with viral 
DNA and transferred to a secondary host contributing to the environmental spread of plasmids 
(Shrivastava, 2013). 
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1.3.2.3 Incompatibility Group 
 
Once transferred to a host cell the new plasmid must undergo DNA replication to increase its copy 
number and be maintained within the bacterial cell. This is accomplished using host machinery to 
replicate the circular plasmid DNA by the same process as host chromosomal DNA replication (del 
Solar et al. 1998; Wang et al. 2009). 
 
Plasmid replication begins at the origin of replication (ORI), a gene sequence which host replication 
machinery recognises and binds to initiate DNA replication. Typically, origins have a higher ratio of 
AT than GC base pairs, as AT base pairs are bound by 2 hydrogen bonds and are more readily 
denatured than the 3 hydrogen bonds found in GC base pairs. This lower melting point of origins 
allows for easier binding of replication machinery and a higher chance of plasmid retention within 
the bacterial cell (Thomas, 2014).  There are many identified plasmid origins, including pSC101, R6K 
and 15A, which can be found in varying locations on the plasmid. Each origin produces a different 
copy number once replication has initiated, which is controlled by a negative feedback loop and has 
implications in protein expression and plasmid retention. Plasmids with a higher copy number are 
more likely to be expressed and retained within the host cell, compared to their low copy number 
counterparts (Nordstrom and Dasgupta, 2006; Carattoli, 2009).  
 
Plasmids with origins of a similar sequence may be unable to co-exist within the same host without 
removal of one or both plasmids, this is known as plasmid incompatibility. A similar origin may result 
in plasmid removal due to competition for replication and regulation machinery, however sharing 
addiction and partition systems that require similar cellular elements may also lead to plasmid 
incompatibility. Incompatible plasmids are not always lost symmetrically from a host bacterial cell as 
the presence of secondary genetic features, such as a second ORI gene, may result in the retention 
of one plasmid and the removal of another. Several mathematical models have been created to 
simulate the inheritance of multiple plasmids which share an ORI gene (Carattoli, 2009; Thomas, 
2014).  
 
The Incompatibility (Inc) groups a plasmid belongs to can reveal vital information, such as host range 
and potential copy number, which are useful in understanding how the plasmid behaves in a 
bacterial population. Plasmids of the same Inc group cannot stably co-exist in a bacterial cell as they 
show homology in the ORI and partition genes necessary for replication and plasmid segregation. 
This homology results in competition for replication machinery within the cell, and the eventual 
removal of a plasmid. PCR techniques have been developed to quickly identify plasmid 
incompatibility groups which utilise primers designed to bind to any origin of the same Inc group. 
Currently Carattoli, A. et al have developed the most comprehensive PCR system for the detection of 
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plasmid Inc group, identifying 18 Inc groups including IncN, IncP and IncF. However, Inc group 
identification by PCR can be unreliable as some plasmids can exhibit multiple ORI genes of different 
Inc groups, a phenomenon particularly observed in IncF plasmids (Carattoli et al. 2005; Carattoli, 
2011; Thomas, 2014).  
 
1.3.2.4 Addiction Systems 
 
Most plasmids have a symbiotic relationship with their bacterial host by providing resistance to 
antibiotics in the natural environment. Under these conditions antibiotic resistant plasmid-
containing bacteria are naturally selected due to their increased survivability, encouraging plasmid 
maintenance in the bacterial population. However, if selective pressure is removed the plasmid no 
longer provides increased survivability and increases metabolic burden on host cells, making plasmid 
loss likely (Zielenkiewicz and Cegłowski, 2001). To prevent removal from the host cell many plasmids 
contain an addiction system to make plasmid removal detrimental to survivability even in the 
absence of environmental selective pressure. There are 2 main addiction systems observed in the 
natural environment, Antitoxin-Toxin (AT) systems and metabolism based (MB) systems (Kroll et al. 
2010).  
AT systems rely on the production of an unstable antitoxin and a more stable toxin encoded on the 
plasmid which bind to form a harmless dimer, these can be protein, antisense RNA or restriction 
modification mediated. During protein translation the more stable toxin is expressed at low levels 
while the unstable antitoxin is highly expressed. Cell survival continues while both toxin and 
antitoxin proteins are translated at the correct ratio, however should the plasmid be removed the 
antitoxin is degraded at a quicker rate than the toxin, leading to its accumulation within cell 
cytoplasm resulting in cell death and ensuring plasmid maintenance within the population (Kroll et 
al. 2010). Common AT protein systems include plasmid energy maintenance (PemKI), coupled cell 
division locus (ccdAB) and virulence associated protein (vagCD) (Mnif et al. 2010). 
 
Antisense RNA systems use the same principle; however, an unstable RNA antisense molecule is 
produced which forms a dimer with a stable toxin mRNA molecule to prevent translation of toxin 
proteins. Following plasmid removal the stable toxin mRNA is not inactivated by missense RNA and is 
translated to a protein toxin which accumulates in cell cytoplasm causing cell death (Gerdes et al. 
1997). Common AT RNA antisense systems include host killing (hok-sok) and promotion of nucleic 
acid degradation (pndAC) (Mnif et al. 2010). 
 
The restriction modification model relies on two plasmid encoded antagonistic enzymes, a 
restriction endonuclease and a DNA modification enzyme. Upon expression of the modification 
enzyme the target sequence on the host chromosome is methylated rendering the host immune to 
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the expressed endonuclease while plasmid expression is maintained. Upon removal of the plasmid, 
methylation of the target sequence no longer occurs allowing restriction by endonuclease enzymes 
causing DNA damage and cell death (Handa and Kobayashi, 1999). The EcoRI sites are often targeted 
in plasmid containing E. coli (Kroll et al. 2010).  
 
In MB systems a host gene vital for metabolism is inactivated and replaced by plasmid expression of 
a homologous gene, these can be divided into catabolism and anabolism based. In catabolism-based 
systems a gene encoding enzymes necessary for the degradation of carbon atoms in energy sources 
is inactivated, however metabolic activity is restored by plasmid expression of an enzyme with 
comparable activity. In anabolism-based systems an enzyme necessary for cell growth and repair is 
inactivated and again is replaced by plasmid expression of a similar gene. In both these systems cell 
metabolism is able to continue while the replacement homologous plasmid gene is transcribed, 
upon plasmid removal metabolism is interrupted resulting in cell death (Kroll et al. 2010).  
 
These systems provide a novel target for the removal of resistance plasmids from environmental 
bacterial populations. Chemical agents which prevent the expression of antitoxin, antisense RNA or 
modification proteins could in theory be utilised to remove a cells protection to addiction mediated 
systems, lowering the number of plasmid containing bacteria and reducing plasmid mediated 
antibiotic resistance. This would reduce the overall levels of resistance expression in the 
environment and may lower the size of antibiotic resistance reservoirs, slowing the spread of 
resistance genes in both a clinical and environmental setting. This approach of combatting the 
source of antibiotic resistance as opposed to developing new antibiotics to fight already resistant 
organisms could allow the return of obsolete antibiotics to clinical use. Polymixin antibiotics were 
used approximately 30 years ago in the treatment of Gram-negative infection, however they were 
abandoned due to reports of decreasing efficacy and increasing toxicity. Following the emergence of 
multi drug resistant infection in recent years polymyxin E, also known as colistin, has been used as a 
last line antibiotic with a much higher efficacy and lower toxicity than previously reported, likely due 
to a lower prevalence of colistin resistance genes driven by the hiatus in polymyxin antibiotic use 
(Falagas et al. 2005).  
 
1.4 Waste Water Effluent and the Natural Environment 
 
1.4.1 The Waste Water Treatment Process 
 
Waste water from residential, commercial and other sources from around the UK is directed 
towards waste water treatment (WWT) facilities. These facilities use a number of physical chemical 
and biological processes to remove harmful and pollutant elements from waste water before 
returning it back to the natural environment.  
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In the primary stage of WWT, solids, known as total suspended solids (TSS), are removed by filtration 
and sedimentation. Large particulate matter such as grit and sand are removed at this stage by 
allowing them to separate in large settling tanks, and the waste water transferred to the second 
stage of treatment. The second stage focuses on the removal of biological matter and aims to reduce 
the biological oxygen demand of the water. This is achieved by a variety of processes and varies 
around the country, but usually involves either the activated sludge process, membrane bioreactors 
or a rotating biological reactor. However, the most common form of sewage treatment is sand 
filtration, this uses layers of sand as filters to pass untreated water through and is often combined 
with chemicals, such as rapid and upward flow sand filters, however slow sand filters do not require 
the use of chemicals Trickle bed reactors are also common, and use a solid medium such as rocks, 
gravel or other sediment to establish an organic biofilm which absorbs or adsorbs pollutant such as 
nitrates and organic matter (Haig, S.J et al. 2011; Rittmann & Snoeyink 1984.)  . Some WWT facilities 
utilise a final tertiary stage of treatment, however this varies depending on the treatment site. 
Disinfection is the most common tertiary process, with chlorination treatment the standard, 
however further treatment process is required to remove chlorine contamination from WWE before 
its release to prevent environmental pollution.  Deep bed filtration can also be carried out to remove 
further solid waste following secondary treatment. Currently in the UK over 9,000 WWT facilities 
discharge WWE into natural in land waters and estuaries (DEFRA, 2002; DEFRA, 2012).  
 
1.4.2 Pollution of Natural Aquatic Environments by Waste Water Effluent Release 
 
Despite the stringent treatment processes in place for waste water in the UK, several studies have 
been undertaken investigating the chemical and biological pollution caused by the release of WWE 
into natural aquatic environments. 
 
One source of chemical pollution is from incompletely metabolised antibiotics found in domestic, 
agricultural and hospital waste water. These residual antibiotics are not always effectively removed 
during treatment and are found at detectable levels in natural water systems receiving WWE. A 
Study of WWE in Wisconsin, USA detected 6 different antibiotic compounds: sulfamethazine, 
sulfamethoxalone, tetracycline, ciprofloxacin, erythromycin and trimethoprim, at concentrations less 
than 1.3 µg/L. Similar results have been obtained in European studies, however antibiotic 
concentrations were slightly lower (Karthikeyan and Meyer, 2006). The river of interest for this 
study, Sincil Dike, Lincoln, UK, was tested for concentrations of the antibiotic cefotaxime, with 
results suggesting the antibiotic was not present. However, the study identified several issues with 
the detection method used, including improper sample preparation and lack of standard spike 
introduction during HPLC. Therefore, it is still possible that Sincil Dike, Lincoln UK contains antibiotic 
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contamination similar to that found globally, but more sensitive and refined analytical techniques 
are required for its detection (Cheswick, 2014).  
 
As well as chemical pollution, WWE release also introduces biological pollutants to the natural 
environment. A study has shown that large numbers of bacteria are able to survive the water 
treatment process, and are released into the natural environment with WWE. A high proportion of 
these organisms have been shown to be ESBL producing E. coli (ESBLEC), with up to 600 million 
released by WWE into the environment daily (Brechet et al. 2014). It has been identified that these 
large numbers of organisms are able to persist through the WWT process due to inadequate removal 
of organic matter during disinfection, with the CFU/ml of antibiotic resistant organisms unaffected 
after chlorine disinfectant treatment (Munir et al. 2011) 
 
From the studies performed on the purity of WWE released into natural environments, it is apparent 
that the current WWT process is not stringent enough to ensure the removal of all harmful 
contaminants before its release into the environment. Therefore, a review of the current treatment 
technologies and investigation into how they can be refined would improve the health of our natural 
waterways and prevent the introduction of resistant bacteria to the environment. 
 
1.4.3 The Effects of Waste Water Effluent Release on Antibiotic Resistant Organisms   
 
It has been previously shown that release of WWE into natural aquatic environments introduces a 
variety of chemical and biological pollutants, however, a little study has been conducted on how the 
introduction of these pollutants effects the native bacterial population and the levels of resistance 
within this population.  
 
A study of river sediment samples collected between 2009 and 2011 from the midlands, UK, both 
upstream and downstream of WWE release points, showed a significant increase in third generation 
cephalosporin resistance in isolates exposed to WWE. It was also shown that this increase in 
resistance was caused by dissemination of the group 1 CTX-M gene CTX-M-15, which is often 
associated with resistant nosocomial infection. However, it was not clear if CTX-M-15 bearing 
plasmids were introduced by WWE or already existed in the environment and were allowed to 
proliferate. It was hypothesised that increased proliferation could be due to favourable conditions 
caused by the introduction of WWE, such as the presence of antibiotic residues which drove natural 
selection (Amos et al. 2014).  
 
A 2014 study of the Sincil Dike, Lincoln, UK found similar results to that obtained by Amos, et al. 
2014. Water samples were collected upstream at the point of and downstream of WWE release and 
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colony counts of ESBLEC performed, these isolates were then screened for phenotypic and genotypic 
antibiotic resistance. It was determined that ESBLEC counts were significantly higher at the point of 
and downstream of WWE release. Comparison to a nearby river not receiving WWE showed a 10-
fold increase in the number of ESBLEC isolated from sites exposed to WWE. It was hypothesised that 
this dramatic increase can be attributed to the introduction of resistant organisms by WWE, and 
rapid horizontal gene transfer of plasmid associated antibiotic resistance genes (Cheswick, 2014). 
  
The small body of evidence currently available suggests that the introduction of contaminates by 
WWE has a significant and measurable effect on the prevalence of antibiotic resistant organisms, 
particularly those carrying ESBL genes such as the CTX-M family. To fully understand the effect of 
WWE, larger scale study is needed which focuses on the origin of the increase in resistance, and the 
specific genetic and chemical mechanisms responsible.  
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1.5 Aims and Objectives 
 
The aim of this study was to perform a series of genetic analysis on plasmids extracted from ESBLEC 
isolated from aquatic environments receiving WWE. This analysis revealed the genetic elements 
present on circulating plasmids, which were then used to develop a plasmid architecture of 
commonly associated genetic elements to characterise, and track the environmental spread of 
antibiotic resistance carrying plasmids through the addition of WWE.  
 
Initially water samples from a river receiving WWE were collected at three points, 500m up stream 
of WWE release, at the point of WWE release and 500m downstream of WWE release. This provided 
a natural control of samples that have not been in contact with environments receiving WWE. 
Samples were filtered onto selective media for ESBLEC, however subsequent biochemical testing 
was used to confirm bacterial species and ESBL production independently.  
 
Extracted plasmid from these samples was used in PCR for the detection of ESBL, incompatibility 
group and addiction system genes. The prevalence of each gene was assessed and compared to 
current published data, and the effects of WWE on the incidence of each gene studied. Finally, the 
genetic data for each sample was arranged into the common genotypes observed and analysed to 
determine how these genotypes changed with the addition of WWE.  
 
This information allowed for a better understanding of the genetic elements currently present on 
plasmids isolated from ESBLEC and how addition of WWE effects the genetics of ESBL producing 
organisms.  
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Chapter 2 - Methods and Materials 
 
2.1 Media and Supplements 
 
2.1.1 Brilliance ESBL Chromogenic Agar 
 
Brilliance ESBL chromogenic agar plates (Oxoid, PO5302) were used to isolate presumptive ESBLEC. 
Plates were purchased prepared, and under optimum conditions are able to presumptively identify 
E. coli, KESC (Klebsiella, Enterobacter, Serratia and Citrobacter), Proteus, Morganella and providencia 
species (Figure 3). Plates were stored at 4°c until the stated use by date.  
 
 
 
Figure 3. Chromogenic change of ESBL brilliance agar when cultured with identifiable species  
(Oxoid, 2010) 
 
 
Typical Formula   g/L        
Sodium Chloride                                         5.0 
Peptones                                                   12.0 
Phosphate Buffers                                    4.0 
Chromogenic Mix                                   4.0 
Antibiotic Mix                                              0.28 
Agar                                                   15.0 
 
2.1.2 Agar Technical No.3 
 
1.2% w/v agar technical no.3 (Oxoid, LP0013) was added to broth media to create a solid media. 
Agar powder was added to the broth solution and autoclaved according to broth media instructions. 
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2.1.3 Membrane Lauryl Sulphate Agar (MLSA) 
 
MLSA was used for confirmation of E. coli after presumptive identification from Brilliance ESBL 
chromogenic agar (2.1.1). 76.2 g of membrane lauryl sulphate broth (Oxoid, MM0615) powder was 
dissolved in 1 L of distilled water with 1.2 g of agar technical no.3 (2.1.2), and autoclaved at 121°c for 
15 minutes. After autoclaving, molten agar was poured into polystyrene Petri dishes (Fisher 
Scientific, AS4052) and allowed to cool until set, plates were stored at 4°c for up to 3 weeks.  
 
Typical Formula   g/L     
Peptone                                                        39.0 
Yeast Extract                                                6.0 
Lactose                                                 30.0 
Phenol Red                                                   0.2 
Sodium Lauryl Sulphate                           1.0 
Agar Technical no.3                                   12.0 
 
2.1.4 Nutrient Broth 
 
Nutrient Broth (Oxoid, CM0001) was used as a general liquid growth medium. 13 g of nutrient broth 
powder was dissolved in 1 L of distilled water and transferred to glass universals in 10 ml aliquots. 
The universals were autoclaved at 121°c for 15 minutes and stored at room temperature for up to 3 
months. 
 
Typical Formula   g/L 
‘Lab-Lemco’ Powder                               1.0 
Yeast Extract                                                2.0 
Peptone                                                        5.0 
Sodium Chloride                                         5.0 
 
2.1.5 Nutrient Agar         
               
Nutrient Agar (Oxoid, CM0003) was used as a general solid growth medium. 28 g of nutrient agar 
powder was dissolved in 1L of distilled water and autoclaved at 121°c for 15 minutes. After 
autoclaving molten agar was poured into polystyrene petri dishes (Fisher Scientific, AS4052) and 
allowed to cool until set, plates were stored at 4°c for up to 3 weeks. 
 
Typical Formula   g/L 
‘Lab-Lemco’ Powder                               1.0 
Yeast Extract                                                2.0 
Peptone                                                        5.0 
Sodium Chloride                                         5.0 
Agar     15.0 
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2.1.6 Cefotaxime Stock Solution 
 
Cefotaxime was used as an additive to solid and liquid media for the selection and maintenance of 
ESBLEC. 0.1 g of cefotaxime sodium salt (Sigma-Aldrich, C7039) was dissolved in 50 ml of distilled 
water to create a 1000x stock (2 g/L). The stock solution was passed through a 0.45µm nylon filter 
(Fisher Scientific, 09-719D) to sterilise and stored in 0.5ml aliquots at -20°c. 
 
 
2.1.7 Cefotaxime Supplemented Nutrient Agar 
 
Cefotaxime supplemented agar was used to maintain cefotaxime resistant ESBLEC. Nutrient agar 
was prepared as described above (2.1.5) but autoclaving the media was allowed to cool to 55°c and 
1 ml of cefotaxime stock solution (2.1.6) was added to 999 ml of media and thoroughly mixed. The 
supplemented molten agar was poured into polystyrene petri dishes (Fisher Scientific, AS4052) and 
allowed to cool until set, plates were used immediately. This gave a final cefotaxime concentration 
of 2mg/ml as described previously (Doumith et al. 2012).   
 
2.1.8 Mueller-Hinton Agar 
 
Mueller-Hinton agar (Oxoid, CM0337) was used during combination antibiotic susceptibility disc 
testing. 38 g of Mueller-Hinton agar powder was added to 1 L of distilled water and autoclaved at 
121°c for 15 minutes. After autoclaving molten agar was poured into polystyrene petri dishes (Fisher 
Scientific, AS4052) and allowed to cool until set, plates were stored at 4oc for up to 3 weeks. 
 
 
Typical Formula   g/L        
Beef, Dehydrated infusion from  300.0 
Casein hydrolysate   17.5 
Starch     1.5 
Agar     17.0 
 
2.1.9 Tryptone Broth 
 
Tryptone broth was used as a growth media during the indole test (2.2.3). 10g of tryptone (Oxoid, 
LP0042) and 5g of sodium chloride (Oxoid, LP0005) was dissolved in 1L of distilled water and 
transferred to test tubes in 5ml aliquots. The test tubes were autoclaved at 121°c for 15 minutes and 
stored with caps at 4oc for up to 1 month.  
 
Typical Formula                                             g/L        
Tryptone                                                         10.0 
Sodium Chloride                                            5.0 
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2.1.10 LB Broth 
 
LB broth (Fisher Scientific, BP9723) was used as a culture medium for E. coli prior to plasmid 
extraction (2.4.1.2). 37 g of LB broth granules was dissolved in 1 L of distilled water and transferred 
to glass universals in 10 ml aliquots. The universals were autoclaved at 121°c for 15 minutes to 
sterilise. 
 
Typical Formula                                              g/L        
Casein peptone     10.0 
Yeast Extract                                                   5.0 
Sodium Chloride                                            10.0 
 
2.2 Isolation of ESBL Producing E.coli 
 
2.2.1 Sample Collection Method 
 
Samples were taken at 3 different sites from the Sincil Dike, Lincoln, UK. Samples were taken 500m 
upstream of the wastewater effluent release point, at the release point and 500m downstream of 
the release point (Figure 4). Samples were collected approximately 30 cm below the surface in a 500 
ml screw-top Duran bottle sterilised by autoclaving. Samples were filtered on the day of collection 
(2.2.2.2). 
 
 
 
Figure 4. Map of WWT facility and sample points S1 (500m upstream of WWE release point), S2 (At 
WWE release point) and S3 (500m downstream of WWE release point). 
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2.2.2 Sample Filtration and Bacterial Isolation 
 
2.2.2.1 Filter Membranes 
 
Gridded cellulose nitrate membrane filter discs of pore size 0.45 µm (Nalgene, DS0205) were used 
during water sample filtration. 
 
2.2.2.2 Differentiation of ESBL Producing Organisms 
 
A vacuum pump (Liquiport, NF 100) was connected to filtration manifolds (Sartorius, Combisart) and 
sterilised by Bunsen burner with all valves fully open, manifold cups were sterilised separately using 
a clamp stand and Bunsen burner. Flat forceps were ethanol sterilised and used to place a sterile 
0.45µm cellulose nitrate filter (2.2.2.1) onto the filtration pedestal. A manifold cup was placed over 
the filter and clamped in place with the valve closed. 100ml of water sample was transferred to the 
manifold cup and the valve opened until all sample had been drawn through the filter. The manifold 
cup was removed and the filter transferred using ethanol sterilised forceps to the surface of 
Brilliance ESBL agar (2.1.1) ensuring the filter remained face up with no trapped air between the 
filter and agar surface.  
 
Brilliance ESBL agar plates (2.1.1) were then incubated at 37°c for 24 hours, presumptive ESBLEC 
colonies were selected by a chromogenic change to blue or pink, and sub cultured by streak plate 
onto MLSA (2.1.3) to confirm presence of E. coli. MLSA plates (2.1.3) were incubated at 30°c for 4 
hours followed by 44°c for 14 hours, yellow colonies indicated the presence of E. coli and were 
retained for further testing.  
 
E. coli ATCC 25922 was used as a negative control strain and K. pneumoniae ATCC  700603 used as a 
positive control strain as recommended by the Brilliance ESBL agar data sheet. These were cultured 
from glycerol stocks created by Cheswick, 2014.  
 
2.2.3 Indole Test   
 
All presumptive E.coli isolates from MLSA testing were confirmed as E.coli by the indole test. 
Tryptone broth (2.1.9) was inoculated with a single colony of each isolate and incubated at 37°c 
overnight.  Isolates were confirmed as E. coli if a cherry red layer was seen on the media surface 
immediately after 5-7 drops of Kovacs reagent (Biorad, 55313) was added. 
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2.2.4 Combination Antibiotic Susceptibility Disc Testing 
 
2.2.4.1 Cefpodoxime Combination Disc Kit 
 
Cefpodoxime combination disk kit (Oxoid, DD0029) was used to confirm the ESBL status of E. coli 
isolates following positive E. coli identification from indole testing (2.2.3). Two types of disc were 
included in the kit, cefpodoxime 10 µg and cefpodoxime + clavulanic acid 10µg/1µg. Discs were 
dispensed onto the surface of Mueller Hinton agar using a disc dispenser (Oxoid, ST6090). 
 
2.2.4.2 Combination Antibiotic Disc Testing Method 
 
All presumptive E. coli isolates from MLSA testing were confirmed as ESBL producers by the 
combination antibiotic disk method (Carter et al. 2000). Nutrient broth (2.1.4) was inoculated with a 
single colony of each isolate and incubated at 37°c overnight. Cultures were diluted to a 0.5 
mcfarland standard and 0.1ml spread onto Mueller-Hinton agar (2.1.8) as described by British 
standards (EUCAST, 2015). 
 
A cefpodoxime and a cefpodoxime+clavulanic acid combination disk (2.2.4.1) were placed on the 
agar surface and incubated at 37°c for 24 hours. Following incubation, zone of inhibition for each 
disk was measured in mm. Organisms were confirmed as ESBL producers if the zone of inhibition 
around the combination disk was ≥5mm larger than that of the cefpodoxime disk alone (Carter et al. 
2000). In this study E. coli NCTC 13353 was used as a positive control and Klebsiella pneumoniae 
ATCC 700603 was used as a negative control as recommended by the product manufacturer and 
were cultured from glycerol stocks created by Cheswick, 2014. 
 
2.3 Long Term Storage of E. coli Strains 
 
2.3.1 50% Glycerol Solution 
 
Sterile 50% glycerol solution was mixed with bacterial culture prior to flash freezing and long term 
glycerol storage. 50g of glycerol (Sigma-Aldrich, G5516) was dissolved in 100ml of distilled water and 
autoclaved at 121oc for 15 minutes.  
 
2.3.2 Glycerol Stock Method 
 
For long term storage glycerol stocks of the isolates were created. 0.5ml of overnight nutrient broth 
culture was mixed with 0.5ml of 50% glycerol solution (2.3.1) in a screw-top cryovial (Sigma-Aldrich, 
BR114840) and flash frozen in liquid nitrogen and stored at -80°c. 
 
2.4 DNA Extraction 
 
2.4.1 Plasmid Extraction 
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2.4.1.1 Monarch Plasmid Mini Prep Kit  
 
For the extraction of pure plasmid DNA from E. coli isolates a Monarch plasmid mini prep kit (New 
England BioLabs, T1010) was used. The kit contains resuspension buffer (B1), plasmid lysis buffer 
(B2), plasmid neutralisation buffer (B3) wash buffers 1 and 2 and elution buffer. The kit also contains 
spin columns used to purify plasmid DNA from other substances following extraction.  
 
2.4.1.2 Plasmid Extraction Method  
 
1.5ml of overnight nutrient broth culture was added to a sterile 1.5ml Eppendorf and centrifuged 
(ThermoFisher, 75002430) at 16,000 x g for 30 seconds and supernatant discarded from the bacterial 
pellet which was resuspended in 200µl of resuspension buffer (B1). 200µl of plasmid lysis buffer (B2) 
was added and gently inverted 6 times until the solution became dark pink and viscous to ensure cell 
lysis had occurred. The solution was then neutralised with 400µl neutralisation buffer (B3), inverted 
until uniformly yellow with a white precipitate and incubated for 2 minutes at room temperature. 
Samples were then spun for 5 minutes at 16,000 x g and the supernatant was transferred to a silica 
spin column and centrifuged at 16,000 x g for 1 minute. Flow through was discarded and 200µl of 
wash buffer 1 added to the spin column before centrifugation at 16,000 x g for 30 seconds, this was 
repeated with 400µl of wash buffer 2 and all flow through discarded. Finally the spin column was 
transferred to a clean 1.5ml Eppendorf tube and 50µl of elution buffer added and left to incubate for 
1 minute before centrifugation at 16,000 x g for 1 minute to elute bound plasmid DNA from the spin 
column (New England BioLabs, 2016). Plasmid samples were stored at 4°c for the duration of the 
project. 
 
2.4.2 Control DNA Extraction Method  
 
Control strains for CTX-M group 1 required extraction of both plasmid and chromosomal DNA as the 
CTX-M group 1 gene could be found on both. Control strains were streak plated onto nutrient agar 
and incubated overnight at 37°c. 3 colonies of each control was suspended in 50µl of PCR grade 
water in a sterile 1.5ml Eppendorf tube and heated to 100°c for 10 minutes in a heat block Samples 
were centrifuged at 17,000 x g for 10 minutes to separate cellular debris and 1µl of the supernatant 
used as template DNA during PCR.  
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2.5 Visualisation of DNA Fragments  
 
2.5.1 TAE Buffer 
 
TAE buffer (Fisher, BP1332) was used to make agarose gels and as a running buffer during 
electrophoresis. A purchased 50x stock solution was diluted to a 1x working concentration using 
distilled water.  
 
Typical Formula                                              %        
 Tris      24.0 
 Acetic acid     5.0 
 EDTA      <2.0 
 
 
2.5.2 Agarose Gels 
 
Agarose gels were used during visualisation of PCR products and restriction enzyme fragments. 0.8-
1.5% w/v agarose powder (Fisher, BP160), depending on the application, was added to 1 x TAE 
buffer (2.5.1) in a clean conical flask and microwaved in 1 minute bursts for 3 minutes, or until 
completely melted. Molten agarose was allowed to cool to 50°c then poured into a casting tray with 
the necessary combs and allowed to set.   
 
2.5.3 Preparation of DNA Ladders 
 
DNA ladders were used during gel electrophoresis to quantify fragment BP size by comparing to 
reference bands of known size in the ladder. Ladders were prepared as shown in Table 5 and loaded 
into agarose gels next to DNA samples. 100bp, 1kb and Lambda DNA-HindIII digest ladders (New 
England BioLabs, N3231, N3232 & N3012) were used in this study, as shown in Figure 5. 
 
Table 5. Components and volumes used in preparation of DNA ladders 
 
 Volume or concentration 
DNA Ladder, 500µg/ml (See below) 0.125µg 
Water 4.75µl 
6x Purple Stain 1µl 
Final Volume 25µl 
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Figure 5. (Left to Right) 100bp Molecular ladder, 1kb molecular ladder and Lamda DNA-HindII digest 
molecular ladder (New England BioLabs, N3231, N3232 & N3012). 
 
 
2.5.4 Gel Electrophoresis Method  
 
Gel electrophoresis was used to separate DNA fragments based on their base pair size and quantify 
them using a DNA ladder (2.5.3). Prepared agarose gels (2.5.2) were placed in an electrophoresis 
tank and filled to approximately 5mm above the agarose gel with 1 x TAE buffer. Samples were 
loaded into individual wells will DNA ladders at the ends of each gel. The gel tank, anode and 
cathode were assembled and connected to a power supply (Biorad, PowerPac) and set at a constant 
of 100V, running time depended on percentage of agarose used and size of the gel, and stopped 
when the loading dye reached approximately 3/4 of the way down the gel.  
 
2.5.5 Ethidium Bromide Staining and Visualisation  
 
Ethidium bromide (Thermo Scientific, 15585011) was used as a DNA stain following agarose gel 
electrophoresis. Ethidium bromide was purchased as a 10 mg/ml solution and 50µl was added to 1L 
of water to give a final concentration of 5µg/ml. Gels were submerged in the ethidium bromide 
solution for 15 minutes following electrophoresis and destained for 10 minutes in distilled water to 
reduce background staining. Gels were then imaged on a ChemiDoc gel imaging system (Biorad, 
1708280) and analysed using ImageLab software suite.  
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2.6 Detection of Plasmid Genetic Elements 
2.6.1 Taq 5x Master Mix 
 
Taq 5x master mix (New England BioLabs, M0285) was used during PCR as a source of DNA 
polymerase and dNTPs. Taq 5x master mix was used in PCR reaction mixtures to a final 1x working 
concentration and stored at -20°C. 
2.6.2 Primer Stock Preparation 
 
Custom primer sequences were used during PCR to bind to specific sequence sites in the target 
gene. First dehydrated primers were briefly centrifuged at full speed to prevent loss and rehydrated 
using the amount of TE buffer recommended by the manufacturer (Sigma-Aldrich) to give a 
concentration of 100µM. Primers were further diluted to 10 µM in TE buffer before being added to 
PCR reaction mixtures to give a final concentration of 1 µM. Table 6 shows primer sequences used in 
this study. 
Gene 
Detected 
Primer Sequence (5’to 3’) Fragment 
Yielded 
(bp) 
Annealing 
temperature ( 
oc) 
Source 
CTX-M 
group 1 
Forward AAAAATCACTGCGCCAGTTC 415 52 (Woodford 
et al. 2006) 
Reverse AGCTTATTCATCGCCACGTT 
IncF repB Fw TGATCGTTTAAGGAATTTTGA 270 52 (Carattoli et 
al. 2005) 
repB Rv GAAGATCAGTCACACCATCC 
IncN Rep 1 AGTTCACCACCTACTCGCTCCG 164 55 (Gotz et al. 
1996) 
Rep 2 CAAGTTCTTCTGTTGGGATTCCG 
IncP oriT1 CAG CCT CGC AGA GCA GGA T 110 57 (Gotz et al. 
1996) 
oriT2 CAGCCGGGCAGGATAGGTGAAGT 
Hok-Sok Hok up AGATAGCCCCGTAGTAAGTT 203 54 (Mnif et al. 
2010) 
Sok low GATTTTCGTGTCAGATAAGTG 
PemK PemK up AACGAGAATGGCTGGATGC 232 54 (Mnif et al. 
2010) 
PemK 
low 
CCAACGACACCGCAAAGC 
ccdAB ccdB low AGGAAGGGATGGCTGAGGT 230 54 (Mnif et al. 
2010) 
ccdA up GGTAAAGTTCACGGGAGAC 
Table 6.  Sequence and yielded fragment sizes of primers used in this study. 
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2.6.3 PCR Reaction Mix  
 
 
PCR reactions were setup in 0.2ml PCR tubes as described in Table 7. Template plasmid DNA was 
quantified using a Nanodrop 2000 (ThermoFisher, ND-2000) and diluted to 1ng/µl in PCR grade 
water. 
 
 
 
 
 
 
 
 
 
 
Table 7. Components, volumes and final concentrations used in assembly of PCR reaction mix 
 
2.6.4 PCR Cycling Conditions 
 
PCR reaction mixtures were placed in a thermocycler (Biorad, T100) for amplification of the target 
gene. Tables 8-11 show the cycling conditions for each gene detected. Following thermos cycling 5µl 
of PCR product was mixed with 1µl of 6x purple stain (New England Biolabs, B7024S) for agarose gel 
loading. 
 
PCR Step Temperature and Duration 
Initial Denaturation 94°c for 5 minutes 
35 Cycles 94°c for 40 seconds 
X°c for 40 seconds 
72°c for 50 seconds 
Final Elongation 72°c for 6 minutes 
 
Table 8. PCR cycling conditions for CTX-M group 1 (X represents the annealing temperature used. 
See Table 5). 
 
 
 
 
 
 
 
 
 
 
 
Volume Final Concentration 
Taq 5x Master Mix 5µl 1x 
Diluted Primer 2µl 1µM 
Diluted Template DNA 1µl 1.0 ng 
Water 17µl - 
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PCR Step Temperature and Duration 
Initial Denaturation 94°c for 5 minutes 
35 Cycles 94°c for 1 minute 
X°c for 30 seconds 
72°c for 5 minute 
Final Elongation 72°c for 10 minutes 
 
Table 9. PCR cycling conditions for IncF (X represents the annealing temperature used. See Table 5). 
 
PCR Step Temperature and Duration 
Initial Denaturation 94°c for 5 minutes 
35 Cycles 94°c for 1 minute 
X°c for 1 minute 
72°c for 1 minute 
Final Elongation 72°c for 5 minutes 
 
Table 10. PCR cycling conditions for IncN and IncP (X represents the annealing temperature used. 
See Table 5). 
 
 
PCR Step Temperature and Duration 
Initial Denaturation 94°c for 5 minutes 
35 Cycles 94°c for 40 seconds 
X°c for 1 minute 
72°c for 1 minute 
Final Elongation 72°c for 5 minutes 
 
Table 11. PCR cycling conditions for Hok-Sok, Pemk and ccdAB (X represents the annealing 
temperature used. See Table 5). 
 
2.6.5 Preparation of sample for gel electrophoresis 
 
6 x Loading dye was mixed with PCR grade water in a 2:5 dye:water ratio. 7µl of PCR product was 
mixed with 5µl of 2:5 dye:water mix and loaded into a 1.5% agarose gel and ran at 100V for 
approximately 90 minutes followed by ethidium bromide staining and visualisation.  
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2.7 Full procedure workflow 
 
Water samples were collected from the 3 sites of the Sincil Dike shown in Figure 3, 500m upstream 
of the WWE release (S1), at the point of WWE release (S2) and 500m downstream of WWE release 
(S3) (2.2.1). Samples were collected twice during the project, then filtered and cultured on Brilliance 
ESBL agar under specific conditions to presumptively identify ESBLEC (2.1.1). Colonies suspected as 
the organism of interest by Brilliance ESBL agar were sub cultured onto MLSA agar (2.1.3) to identify 
E. coli (2.2.2.2), which were sub-cultured in tryptone broth (2.1.9) for confirmation as E. coli by the 
indole test (2.2.3). Once confirmed as E. coli all samples were cultured in nutrient broth (2.1.4) and 
prepared for antibiotic susceptibility testing to confirm ESBL production by the combination 
antibiotic disk method (2.2.4.2). Samples confirmed as E. coli by indole testing and ESBL producing 
by combination antibiotic disk testing were cultured in nutrient broth (2.1.4). Plasmid DNA of each 
sample was extracted using a plasmid mini prep kit for future genetic analysis (2.4.1.2) and bacterial 
isolates were prepared as glycerol stocks for long term storage (2.3.2).  
Plasmid extracts were used as template DNA in PCR reaction mixtures (2.6.3) containing a single 
primer pair specific to the gene detected (2.6.2). PCR reaction mixtures were cycled in a 
thermocycler (2.6.4) and visualised by gel electrophoresis on a 1.5% agarose gel (2.6.5) followed by 
ethidium bromide post stain and imaging (2.6.5) to determine the presence of DNA fragments of the 
expected size (2.6.2). A negative (E. coli ATCC 25922) and positive (E. coli NCTC 13353) control were 
used to ensure the validity of CTX-M group 1 PCR results. DNA from these strains was extracted 
separately to yield both chromosomal and plasmid DNA as CTX-M Group 1 can be both 
chromosomal and plasmid borne. Control strains for the other genetic elements detected could not 
be obtained.  
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Chapter 3 – Isolation of ESBLEC and Characterisation of Circulating Plasmid     
Genotype 
 
3.1 Introduction 
 
Research has previously shown that WWE contains high levels of ESBL producing Enterobacteriaceae 
despite its stringent cleaning process, and its release into river environments causes an increase in 
the total numbers of ESBL producing bacteria observed. It is understood that this increase in ESBL 
production is associated with the introduction of highly prevalent ESBL genes such as the CTX-M 
family, which are frequently disseminated by horizontal genetic transfer of plasmid DNA (Amos et al. 
2014). However, less is known about how the addition of WWE affects other secondary genetic 
factors of bacterial plasmids such as incompatibility group or addiction systems. In the first section 
of this study ESBLEC were isolated pre, during and post WWE addition to compare the prevalence of 
ESBLEC and determine the plasmid genetic elements they contain.  
ESBLEC were isolated from 3 sites of the Sincil Dike, Lincoln, UK to assess the effect of WWE 
introduction on numbers of circulating ESBL producing bacteria. Plasmid DNA was extracted from 
each isolate and characterised by PCR for 3 incompatibility groups, 3 addiction systems and the CTX-
M group 1 ESBL genes. These characterised plasmids were then arranged into groups of the common 
genetic elements they contained, and the occurrence and persistence of these groups was studied 
before, during and after the addition of WWE. This revealed the effect of WWE on the plasmid 
genotypes present in isolated ESBLEC and the prevalence of each element detected.  
 
3.2 Results 
 
In total 88 ESBLEC were isolated from all sample sites, 13 from S1 containing 6 unique plasmid 
genotypes, 40 from S2 containing 15 unique plasmid genotypes and 35 from S3 containing 14 unique 
plasmid genotypes. Table 12 shows each genotype with the genetic elements it contained, with the 
number of organisms it was detected in by sample site. Figure 6 shows a bar chart of the number of 
ESBLEC isolated by sample site.   
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Table 12. Table of ESBLEC isolated and the plasmids genotype contained by sample site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. A bar chart to show the number of ESBLEC by sample site 
 
 
 
 
 
 
 
In text 
genotype 
designator 
Addiction 
systems 
Incompatibility 
group 
CTX-M 
group 1 
status 
Number 
isolated 
from S1 
Number 
isolated 
from S2 
Number 
isolated 
from S3 
α 3 IncF + 5 8 5 
β 3 IncF - 0 5 4 
γ 3 IncF, IncN + 0 1 1 
δ 3 IncF, IncN - 0 1 0 
ε 3 IncF, Inc P - 0 1 0 
ζ 3 None Detected + 3 0 1 
η 3 None Detected - 0 0 1 
θ 2 IncF + 0 2 7 
ι 2 Inc F - 1 2 2 
κ 2 IncF, IncN - 0 0 1 
λ 2 IncF, IncP + 0 1 0 
μ 2 IncF, IncP - 0 2 0 
ν 2 None Detected + 2 4 3 
ξ 2 None Detected - 1 0 0 
ο 1 IncF + 1 2 0 
π 1 IncF - 0 3 2 
ρ 1 IncF, IncN - 0 0 1 
σ 1 None Detected + 0 4 3 
τ 1 None Detected - 0 2 3 
υ None Detected None Detected + 0 2 1 
   Total 13 40 35 88 
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3.3 Discussion 
  
3.3.1 Effect of WWE on Number of ESBLEC Isolated 
 
At the point of WWE release the number of ESBLEC isolated increased from 13 to 40 (Figure 5). An 
increase in the number of resistant and non-resistant organisms was expected at this site as the 
result of an in influx of ESBLEC that survived the WWT process, as WWE has been shown in previous 
study to release over 600 million ESBLEC into a river environment daily (Brechet et al. 2014). Amos 
et al. 2014 measured the number of isolated third generation cephalosporin (3GC)-resistant E. coli 
found in river sediment samples upstream and downstream of a WWE release point, and reported 
similar results of a 7-fold increase in the number of 3GC-resistant bacteria. This suggests the increase 
in the number of resistant organisms found both at the point of WWE release and further 
downstream was due to the influx of ESBL producing bacteria shown to be present in WWE.  
 
Further downstream the number of ESBLEC isolated remained higher than in the natural 
environment but decreased compared to levels observed at the site of WWE release to 35 (Figure 5). 
This could demonstrate that ESBLEC introduced by WWE were able to persist through the natural 
environment, however the number begins to decrease as the environment regains its natural stasis.  
 
This stabilisation could be caused by increased competition between newly introduced ESBLEC that 
have lower survivability in the new environment compared to native organisms. 
The number of ESBLEC isolated may also have been affected by the time of year sampling was 
carried out. A study has shown that a higher rate of faecal E. coli shedding occurs in cattle in England 
and Wales during the summer months, where heavy rainfall can then cause these organisms to be 
washed into natural aquatic environments where they cause an increase in the number of human E. 
coli infections (Money P et al. 2010). This is supported by figures released by the CDC in 2015 which 
observed an increased infection rate of E. coli O157 in the months of July-September, in particular it 
noted an increase in Waterborne transmission in June and leafy vegetable associated transmission in 
September (Heiman KE et al. 2015). As the Sincil dike is surrounded by agricultural land and sampling 
carried out in September 2015 and June 2016, there may have been an unusually high number of 
ELBEC sampled, compared to cooler winter months. 
 
As significantly less ESBLEC were isolated from S1 than S2 or S3, the number of each plasmid type 
detected at each site was used to compare the prevalence of each plasmid type at a sample site, as 
the number of each plasmid type detected represents a proportion of the bacterial population at 
that site. When comparing the prevalence of plasmid types between sample sites a percentage was 
used due to the significantly different population sizes collected from S1, S2 and S3. This allows us to 
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determine how the proportion of each plasmid type changes by sample site despite the varying 
sample size, however this is still a significant limiting factor of this study.   
 
3.3.2 Persistence of Native Plasmid Genotypes  
 
The 13 isolates collected from S1 were arranged into 6 unique genotypes based on the common 
genetic data collected (Table 12). Plasmid types ι, ξ and ο were found in 1 organism each at S1 and 
showed large variation in the genetic elements they contained. This could be due to the random 
transformation of genetic material onto host plasmids from the environment, as exogenous DNA has 
been show to survive in aquatic environments especially when adhered to sand or clay particles, the 
random nature of genetic transformation also explains the low frequency of these plasmids 
(Davison, 1999). Plasmid types α, ζ and ν were present in 5, 3 and 2 isolates respectively at S1 and 
represent part of the dominant microbiome in this environment. These dominant species contained 
2 or more addiction systems and CTX-M group 1 genes on plasmids of IncF or an undetermined 
incompatibility group. These types are likely to be more dominant in the natural unaltered 
environment due to the conferred survivability of CTX-M expression which provides resistance to 
cefotaxime antibiotics commonly found in UK rivers (Singer et al. 2014), while the presence of 
multiple addiction systems ensures plasmid retention and continued expression of resistance genes. 
The high frequency of these plasmids is more likely as a result of clonal expansion and conjugation 
between ESBLEC cells. 
 
At S2 the percentage of isolates containing the dominant plasmid type α and ν increased from 38.5% 
to  20% and from 15.4% to 10% respectively. As the number of these plasmid types appear more 
frequently at S2 they could be carried on ESBLEC shown to be introduced to the environment by 
WWE in section 3.4.1, however they represent a smaller proportion of the population at S2 and are 
no longer the majority type. This also suggests alternate ELBLEC plasmid types were also introduced, 
however conjugation and clonal expansion of both native and introduced plasmid types may also be 
responsible if the introduced types have an improved survivability in the new environment. The 
previously dominant type ν plasmid was eliminated from the environment at S2 and did not belong 
to the highly transferrable IncF incompatibility group observed in other dominant plasmid types. This 
could cause a decreased rate of conjugation, explaining its removal from the environment. It also 
suggests conjugation plays an important role in plasmid incidence in this environment.    
 
Further downstream at S3 incidence of type α plasmids fell from 20% to 14.3% of isolates returning 
to levels observed before the addition of WWE, while incidence of type ν plasmids fell from 10% to 3 
8.6% of isolates, lower than at the site of WWE release, but still more prevalent than at S1. This 
shows that native plasmid types were able to persist throughout the river environment and survive 
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the return to a more stable environment despite a decrease in their overall numbers. The proportion 
of these plasmid types once again decreased at S3, suggesting that while they can survive in the new 
environment, the addition of WWE continues to diversify the plasmid population further 
downstream. These plasmids may contain genetic elements which provide a selective advantage 
over other organisms in the S2 environment, such as the presence of CTX-M group 1 or other 
resistance genes, due to the introduction of antibiotic pollutants by WWE (Brown et al. 2006).  
Further downstream these pollutants may be at a lower concentration, therefore presence of 
resistance genes no longer provides a selective advantage, accounting for the decrease in numbers 
and proportion of these plasmids observed at S3. 
 
3.3.3 Introduction of Novel Plasmid Genotypes by WWE 
 
With the addition of WWE, the number of unique plasmid types increased from 6 at S1 to 15 at S2 
and remained elevated further downstream at S3 with 14 unique plasmid types detected. 
 
At the site of WWE release several new dominant plasmid types appeared, most notably type β 
plasmids which contained 3 addiction systems on an IncF plasmid, similar to the dominant type α 
plasmid observed at S1, however CTX-M group 1 was not detected, indicating the presence of an 
alternate ESBL producing gene. This plasmid type was first observed at the point of WWE release in 
12.5% of isolates at S2 and persisted downstream in 10% of isolates at S3, showing that this new 
dominant genotype is able to persist downstream at a similar level to type α plasmids and its 
prevalence in the population remains steady. This indicates the diversification of ESBL genes present 
on dominant plasmid types with the addition of WWE, while the presence of multiple addiction 
systems and IncF incompatibility group still conferred high survivability and transferability in the new 
environment.  
 
The significant plasmid types σ and π were also introduced with WWE, observed in 10% and 8.6% of 
isolates at S2 and survived downstream in 7.5% and 5.7% of isolates at S3 respectively.  These 
plasmid types contained only 1 addiction system and showed variability in the incompatibility group 
and ESBL gene detected. This shows that while the prolific IncF plasmids containing 3 addiction 
systems are able to prosper in the environment, other plasmids containing a variety of genes are 
also conferred increased survivability by the disruption of environment caused by WWE addition. As 
type τ plasmids contained an unidentified incompatibility group and type ρ contained an 
unidentified ESBL gene it is impossible to determine why these particular plasmids were able to 
survive as well as previously established dominant genotypes. This also suggests the genes present 
on these plasmids confer a similar survivability to the addiction systems and incompatibility groups 
in previously dominant plasmid types.  
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Finally, the type θ plasmid containing 2 addiction systems and CTX-M group 1 genes on an IncF 
plasmid was not detected at S1 but appeared with the introduction of WWE in 5% of isolates at S2, 
with its incidence increasing downstream detected in 20% of isolates at S3. Type θ plasmids differ 
from the previously dominant type α plasmid detected at S1 by loss of a single addiction system, 
therefore It would be expected that these plasmid types would occur at a similar rate throughout 
the sampled river due to genetic homology, however plasmid type θ becomes the most prevalent 
plasmid observed at S3. This strongly suggests that extra genetic factors present on the plasmid or 
chromosome have an important role in the selection and persistence of ESBLEC downstream of 
WWE release, and may play a more significant role in the maintenance of plasmid borne ESBL genes 
than the genetic elements detected in this study.  
 
Overall an increase in the number of unique plasmid genotypes and a decrease in the prevalence of 
the previously most dominant plasmid types was observed with the addition of WWE indicating a 
significant diversifying event, with these plasmids moving from the previously dominant type A to 
several new types with a lower incidence, but more likely to contain fewer addiction systems, 
unknown incompatibility groups and unknown ESBL genes. This could be a result of the introduction 
of ESBLEC carrying novel plasmid types by the addition of WWE, which proliferate by conjugation 
and clonal expansion, or the transformation of genetic material to plasmids which did not previously 
contain ESBL genes. These novel plasmids were also able to persist downstream, though the number 
and occurrence of each type does not appear to depend on the genetic elements they contained.   
 
3.3.4 Role of Pollutants in Natural Selection of Alternate Plasmid Genotypes 
 
A previous study has shown that WWE introduced to the environment contains a significant number 
of resistant organisms including the ESBLEC isolated in this study, however it has also been proven 
that high levels of pollutants such as active antibiotics, heavy metals and disinfectants are also 
carried by WWE. Addition of these pollutants alters the natural environment in which the studied 
bacteria exist and shifts the selective pressures placed on these bacteria (Baquero et al. 2008; Singer 
et al. 2014).  
 
While this study showed that plasmid addiction and transferability play a significant role in the 
persistence of native and novel ESBLEC downstream of WWE release, natural selection of organisms 
expressing resistance genes to pollutants in the environment may also contribute to their 
persistence. Organisms that do not possess resistance genes to the pollutants added at S2 by WWE 
release will be removed from the population allowing more resources for those organisms 
possessing the necessary resistance genes. This natural selection ensures the bacterial population 
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expresses a high level of resistance as bacterial cells incorporate genes which confer resistance to 
the variety of pollutants now present in the environment. Ultimately, the persistence of plasmid 
types throughout the river environment depends on its ability to confer resistance to pollutants 
present in the new environment to its bacterial host.  
 
 
3.3.5 Issues with Sampling and Isolation  
 
The large variation in the number of isolated ESBLEC between S1 and S2 may affect the comparison 
of the incidence of plasmid genetic elements. 100ml of water sample from each site was filtered 
onto Brilliance ESBL plates in an equal number of replicates with all identifiable ESBLEC sub-cultured 
for further testing. Therefore, discrepancy in the number of isolates was due to a lower CFU/ml of 
those organisms in each water sample as opposed to inconsistent sample collection and isolation. 
This change in sample size could lead to a lower detection of genes studied later at S1 when 
compared to S2 which may be falsely attributed to WWE release. As this study focuses on the 
presence of selected genes on ESBLEC rather than their overall occurrence in the environment, 
genetic data will be presented as the increase in raw numbers of isolates positive for the gene of 
interest at each sample site, allowing for direct comparison despite variation in sample number. 
The location for sample collection (Sincil Dike, Lincoln, UK) could not be reached during winter which 
limited sampling opportunities to once in September and once in June. This sample can only be 
representative of the environment at the time of collection as other factors may affect the studied 
parameters. As mentioned previously the prevalence of E. coli infection is higher during June and 
September (Department of Health, 2001), in humans a higher rate of water borne and food borne by 
leafy greens transmission rate is observed (Heiman et al. 2015). This higher incidence of infection 
would cause an increase in the number of ESBLEC detected in WWE.  
 
3.3.6 Evaluation of Brilliance ESBL Agar for the Isolation of ESBLEC 
 
 
Brilliance ESBL agar plates were used for the presumptive identification of ESBL producing bacteria, 
and in this study used to identify ESBLEC. 26/114 (22.8%) isolates shown to be ESBLEC by Brilliance 
ESBL agar were shown by further testing to be incorrectly identified, giving Brilliance ESBL agar an 
overall specificity of 77.2% for the identification of ESBLEC. However the Brilliance ESBL agar data 
sheet states a specificity of 94%, this could lead to the inclusion of non-ESBLEC if supporting 
biochemical testing is not used due to the increased false positive rate. Distinguishing between blue 
or green colonies on brilliance ESBL agar plates was difficult due to similarity in appearance and may 
have resulted in the incorrect selection of K. pneumoniae (Green) instead of E. coli (Blue), 
responsible some of the observed low specificity.  
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The sensitivity of Brilliance ESBL agar could not be calculated as colonies indicated as non-ESBLEC 
were not isolated or verified by further testing, therefore the number of false negatives is unknown. 
The agar data sheet states sensitivity as 95%, if this figure is also inaccurate many ESBLEC colonies 
may not have been isolated. This could mean that the number of ESBLEC isolated from each sample 
site is not representative of the bacterial population.  
3.4 Conclusion 
 
Water samples were collected from Sincil dike, Lincoln, UK upstream, at the point and downstream 
of WWE release and filtered onto Brilliance ESBL agar for the isolation of ESBLEC. Numbers of ESBLEC 
isolated increased following the introduction of WWE at S2 consistent with current research, which 
was attributed to the introduction of WWE shown to carry high levels of resistant bacteria. Plasmid 
was extracted from each ESBLEC isolated and characterised for a range of addiction systems, 
incompatibility groups and CTX-M group 1 family of ESBL genes. This genetic data was then used to 
arrange isolates into common plasmid types. It was discovered that before the introduction of WWE 
there were few unique plasmid types, of which type A F and M formed part of the dominant 
microbiome at this site, some of which were able to persist downstream of WWE and throughout 
the river environment. With WWE addition there was an increase in the number of unique plasmid 
types observed, with a transition from few common type to many less frequent type, many of which 
contained fewer addiction systems, fewer IncF and fewer CTX-M group 1 genes than previously 
observed, these again were able to persist downstream but which plasmids were more prevalent at 
each site appeared to depend on the transferability of the plasmid with possible influence from 
other genetic elements not detected. Overall the introduction WWE to the environment caused a 
significant increase in the number and diversity of circulating plasmid genotypes of ESBLEC.  
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Chapter 4 – Effect of WWE on Prevalence of CTX-M Group 1 
4.1 Introduction 
 
In the previous chapter 88 ESBLEC were isolated from 3 sites of Sincil Dike, Lincoln, UK and it was 
found that introduction of WWE increased the number of ESBLEC isolated, and increased the genetic 
diversity of the plasmid types present by the introduction of resistant organisms with WWE. The 
organisms were able to persist throughout the 100m river environment tested, though survivability 
was dependant on the genetic elements the plasmid contained. In this section the prevalence of 
CTX-M group 1 amongst the ESBLEC isolated in Chapter 3 was determined and the effect of WWE 
addition om incidence of CTX-M group 1 presence amongst ESBLEC plasmids was studied.  
 
4.2 Results 
 
Sample 
Site 
Number of isolates Number of CTX-M group 1 
positive isolates 
% CTX-M group 1 
positive isolates 
S1 13 11 84.6 
S2 40 25 62.5 
S3 35 21 60.0 
Total 88 57 64.8 
 
Table 13. Number and percentage of isolates positive for CTX-M group 1 by sample site 
 
 
 
Figure 7. An example electrophoresis agarose gel for PCR products obtained by CTX-M group 1 
amplification. Lane 1 shows a 100bp DNA ladder, Lane 2 contained the negative control (E.coli  ATCC 
25922) and showed no amplification while lane 3 contained the positive control (E.coli NCTC 23352) 
and yielded a DNA fragment at the expected size of 415 bp. Lanes 6, 7, 10, 14 and 18 contain 
samples 25, 30, 43, 63 and 86 and were positive for CTX-M group 1 showing a 415 bp band. Lanes 4, 
5, 8, 9, 11, 12, 13, 15, 16, 17 and 19 contain samples 4, 20, 35, 40, 47, 48, 51, 66, 67, 68 and 87 which 
were negative for CTX-M group 1 as they showed no PCR product.  
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4.3 Discussion 
 
4.3.1 Effect of WWE on Prevalence of CTX-M Group 1  
 
Overall, CTX-M group 1 was detected in 57 (64.8%) samples and explained the majority of ESBL 
phenotypes at all sample sites. This is consistent with studies which have reported that CTX-M type 
genes are the most prevalent ESBL producing genes detected in natural aquatic environments similar 
to that sampled in this study, with CTX-M group 1 the most prevalent CTX-M group detected in 
municipal waste water. This high incidence of CTX-M genes in the environment is due to horizontal 
transfer of plasmids between bacteria (Brechet et al. 2014; Borgogna et al. 2016).  
A study mentioned in the previous chapter by Amos et al. 2014 demonstrated that WWE increases 
the numbers of 3GC-resistant organisms along with showing that the presence of CTX-M genes 
increased with WWE addition, and attributed this to the introduction of CTX-M carrying bacteria by 
WWE that was able to undergo horizontal gene transfer. In this study the number of CTX-M group 1 
positive samples increasing from 11 (84.6%) before the introduction of WWE at S1 to 25 (62.5%) at 
the site of WWE release, S2, while the percentage that were CTX-M group 1 positive decreased. 
Between S2 and S3 the number and percentage of CTX-M group 1 positive organisms decreased to 
21 (60%), consistent with the decrease in ESBLEC isolated at S3.  
This increase in the numbers with decreasing percentage of the population positive for CTX-M group 
1 shows that while WWE addition increases the instance of CTX-M group 1 amongst ESBLEC 
plasmids, its representation in the population decreases. This can be explained by the introduction 
of alternate ESBL producing genes carried by ESBLEC at the site of WWE release which were not 
detected in this study such as SHV, TEM or other CTX-M groups alongside the introduction of CTX-M 
group 1 carrying ESBLEC, resulting in the diversification of circulating ESBL genotypes. Amos et al 
2014 found high incidence of the ESBL producing gene TEM alongside CTX-M upstream and 
downstream of WWE release, if similar TEM expression is present in the river sampled in the current 
study it is possible that plasmids containing CTX-M group 1 undergo less clonal expansion and 
conjugation due to competition from TEM expressing organisms. Downstream of WWE release 
percentage of CTX-M group 1 decreases slightly and  remains lower than observed before the 
addition of WWE indicating that while ESBLEC carrying novel ESBL genes are able to persist 
downstream, they may begin to diminish due to competition from CTX-M group 1 carrying ESBLEC 
which show resistance to cefotaxime antibiotics present in the environment. 
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4.3.2 Potential issues with Chromosomal Contamination 
Plasmid DNA was extracted from ESBLEC isolates using NEB plasmid mini prep kits. These kits 
required a detergent to initiate cell lysis and release chromosomal and plasmid DNA, followed by a 
sodium hydroxide solution to increase pH and cause denaturation of DNA from a double stranded to 
a single stranded conformation. Potassium acetate was then used to acidify the solution and cause 
the renaturing of plasmid DNA while chromosomal DNA remained single stranded and precipitated 
out of solution. This precipitate was centrifuged into a pellet to leave pure plasmid DNA in solution, 
however carryover of some chromosomal DNA into the plasmid sample was possible. As CTX-M 
group 1 is commonly found both on plasmid and chromosomal DNA it is possible that chromosomal 
contamination could lead to false identification of CTX-M group 1 genes on plasmid DNA. In future to 
prevent chromosomal carryover affecting PCR results plasmid extracts will be transformed into an 
attenuated E. coli laboratory strain such as DH5α to allow greater efficiency during extraction. 
Chromosomal carryover from DH5α is still possible but would not contain any gene detected in this 
study and therefore would not yield a false positive result.  
 
4.4 Conclusion 
 
PCR amplification of CTX-M group 1 genes was performed on 88 ESBLEC isolates to determine the 
prevalence and effect of WWE on CTX-M group 1 genes amongst circulating ESBLEC. CTX-M group 1 
was found in the majority of samples at all sites and explained the ESBL phenotype in most isolates. 
Following the addition of WWE, the number of CTX-M group 1 positive organisms increased 
noticeably and began to return to levels observed before WWE release further downstream, 
consistent with the change in the number ESBLEC isolated previously. It is suspected that 
introduction of other ESBL genes such as SHV and TEM, which were found at high incidence with 
CTX-M in other studies, were introduced by WWE and diversified the genetic source of ESBL 
production by horizontal gene transfer and clonal expansion of novel ESBLEC. These results 
demonstrate the ability of introduced ESBLEC by WWE to persist downstream of WWE release, 
however it appears that native ESBLEC species are able to out compete novel ESBLEC possibly due to 
increased resistance to cefotaxime antibiotics commonly found in this type of environment.   
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Chapter 5 – Effect of WWE on Prevalence of Incompatibility Group 
5.1 Introduction 
 
In the previous chapter the prevalence of CTX-M group 1 genes was studied, and the effect of WWE 
release on incidence of CTX-M group 1 carried on ESBLEC plasmids determined. CTX-M group 1 
expression explained the ESBL phenotype in the majority of samples, with the number of CTX-M 
positive samples increasing with WWE introduction, consistent with the previously established rise 
in ESBL producing organisms. This was attributed to the introduction of novel ESBL genes by WWE 
which were allowed to proliferate, resulting in the diversification in observed ESBL genotypes.  
 
Plasmid associated ESBL genes such as CTX-M are easily disseminated by conjugation in which a 
plasmid is transferred to a recipient cell and undergoes successful replication. To prevent 
competition between plasmids of similar origin, each contains a collection of genes known as an 
incompatibility group, members of each group cannot successfully replicate in the same cell leading 
to removal of one or both plasmids.  
 
In this section the same PCR techniques from chapter 3 were used to establish the presence of 3 
incompatibility groups, Inc F, N and P in each plasmid sample. These groups were selected based on 
their previous association with ESBLEC and availability of singleplex PCR methodology. Prevalence of 
each group and association with CTX-M group 1 genes before and after the introduction of WWE 
was studied to assess its effects on numbers of circulating plasmid incompatibility groups  
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5.2 Results 
 
5.2.1 IncF 
 
Sample 
Site 
Number of 
ESBLEC 
isolates 
Number of 
IncF positive 
samples 
% IncF 
positive 
samples 
Number of IncF 
plasmids positive 
for CTX-M group 1 
%  IncF plasmids 
positive for CTX-
M group 1 
positive  
S1 13 7 53.8 6 85.7 
S2 40 28 70.0 14 51.9 
S3 35 23 65.7 13 56.5 
Total 88 58 65.9 33 57.9 
 
Table 14. Number and percentage of IncN positive samples with number and percentage of those 
positive for CTX-M group 1  
 
 
Figure 8. An example gel for PCR products obtained from Inc F amplification. Lane 1 shows a 100bp 
DNA ladder, lanes 4, 5, 6, 8, 10, 11, 14, 15 and 18 contain samples 5, 6, 9, 31, 35, 36, 44, 45, 74 and 
75 and were positive for Inc F showing an approximately 270 bp band. Lanes 2, 3, 7, 9, 12, 13, 16 and 
75 contain samples 3, 4, 30, 32, 41, 42 and 46 which were negative for Inc F as they showed no PCR 
product. Positive and negative controls could not be obtained for this PCR. 
 
5.2.2 IncN 
 
Sample 
Site 
Number of 
ESLBEC 
isolates 
Number IncN 
positive 
samples 
% IncN 
positive 
Number of IncN 
and 
CTX-M group 1 
positive samples 
%  IncN 
plasmids 
positive for 
CTX-M group 1 
positive 
S1 13 0 0.0 0 0.0 
S2 40 2 5.0 1 50.0 
S3 35 2 5.7 1 50.0 
Total 88 4 4.5 2 50.0 
 
Table 15. Number and percentage of IncN positive samples with number and percentage of those 
positive for CTX-M group 1  
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Figure 9. Example electrophoresis agarose gel of PCR products obtained by IncN amplification. Lane 
1 shows a 100bp DNA ladder, lanes 6, 8, 12 and 16 contain samples 18, 23, 66 and 75 and were 
positive for IncN showing an approximately 164 bp band. Lanes 2, 3, 4, 5, 7, 9, 10, 11, 13, 14, 15, 17, 
18 and 19 contain samples 5, 7, 8, 10, 14, 20, 33, 45, 54, 68, 69, 70, 80 and 82 which were negative 
for IncN as they showed no PCR product. Positive and negative controls could not be obtained for 
this PCR. 
 
 
 
5.2.3 IncP 
 
Sample 
Site 
Number of 
ESBLEC 
isoaltes 
Number 
IncP 
positive 
samples 
% IncP 
positive 
Number of IncP and 
CTX-M group 1 
positive samples 
%  IncP and  
CTX-M group 
1 
positive 
S1 13 0 0.0 0 0.0 
S2 40 3 7.5 0 0.0 
S3 35 0 0.0 0 0.0 
Total 88 3 3.4 0 0.0 
 
Table 16. Number and percentage of IncP positive samples with number and percentage of those 
positive for CTX-M group 1  
 
 
Figure 10. Example electrophoresis agarose gel of PCR products obtained by Inc P amplification. Lane 
1 shows a 100bp DNA ladder, lane 10 contains sample 55 which was positive for Inc P showing an 
approximately 110 bp band. Lanes 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15, 16, 17, 18 and 19 contain 
samples 7, 12, 16, 17, 22, 27, 33, 45, 46, 58, 63, 64, 69, 70, 73 and 82 which were negative for Inc P 
as they showed no PCR product. Positive and negative controls could not be obtained for this PCR. 
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5.3 Discussion 
 
5.3.1 Effect of WWE on Prevalence of IncF Plasmids & Association with CTX-M Group 1 
 
Overall, IncF was observed in 58 (65.9%) isolates and was the most represented incompatibility 
group tested. A study has shown IncF to be the most prevalent incompatibility group amongst 
plasmids harbouring ESBL genes in E. coli and is most often associated with CTX-M ESBL genes, 
particularly CTX-M group 1 members CTX-M-1, and -15 (Marcade et al. 2009). The percentage of IncF 
plasmids detected increased at the point of WWE from 53.8% at S1 to 70.0% at S2. This shows that 
WWE introduced ESBLEC containing IncF plasmids at a higher rate than that already seen in the 
environment, increasing the dominance of this incompatibility group. Further downstream the 
number of ESBLEC carrying IncF plasmids decreased to 65.7%, this subsequent decrease following 
WWE addition could represent the stabilisation of the ESBLEC community as numbers of IncF 
plasmids return to pre-WWE levels suggesting introduced IncF plasmids are unable to persist as well 
as native IncF plasmids.   
IncF plasmids were found to contain CTX-M group 1 genes in 57.9% of cases, comparable with 
results obtained by Wang et al. 2009 which found IncF CTX-M positive plasmids in 64.3% of clinical 
isolates, while Amos et al. 2014 commented that IncF was the most associated incompatibility group 
with CTX-M positive samples in river sediment receiving WWE. At the site of WWE release the 
number of IncF plasmids containing CTX-M group 1 increased from 6 to 14 and remained stable at 13 
at S3, consistent with the increase seen in the number of CTX-M group 1 positive isolates previously. 
This indicates that IncF plasmids carrying CTX-M group 1 genes contribute significantly to the 
increase in CTX-M group 1 observed in chapter 4. However, the percentage of IncF plasmids carrying 
CTX-M group 1 genes decreased between S1 and S2 from 85.7% to 51.9% and increasing to 56.5% at 
S3. This suggest that while IncF plasmids carrying CTX-M group 1 genes are present in WWE, IncF 
plasmids carrying alternate ESBL genes also comprises a significant number of ESBL carrying plasmids 
in WWE. 
 
Marcade et al. 2009 found that IncF plasmids were commonly associated with the CTX-M group 1 
gene CTX-M-15 and the CTX-M group 9 gene CTX-M-14, while Wang, et al 2009 found SHV genes the 
second most commonly IncF associated ESBL gene behind CTX-M, with no instance of TEM type 
genes associated with IncF plasmids. If WWE in this study contains a similar distribution of ESBL 
genes as observed in other studies, it is likely that the increase in IncF plasmids with decreasing 
association with CTX-M group 1 at the point of WWE release is due to the introduction of IncF 
plasmids carrying SHV and CTX-M-14 genes which were not detected in this study. These plasmids 
are able to proliferate easily among ESBLEC by conjugation due to the transformability of IncF 
plasmids leading to an overall diversification of available ESBL genotypes. 
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5.3.2 Effect of WWE on prevalence of IncN plasmids & association with CTX-M group 1 
 
IncN was identified in 4 (4.5%) samples across all sites and was only identified after the addition of 
WWE, in 2 (5%) samples from S2 and 2 (5.7%) samples from S3. Inc N has been detected in clinical 
ESBLEC isolates at low levels consistent with IncN prevalence found in this study (Carattoli, 2011). As 
WWE introduced to the Sincil Dike may contain waste of a clinical origin from the nearby hospital it 
is possible that IncN plasmids were introduced to the environment through WWE. However, IncN 
plasmids carrying ESBL genes are more commonly associated with ESBLEC in animal infection. A 
significant reservoir of IncN plasmids carrying ESBL genes can be found in commercial agricultural 
settings such as poultry, pig, cow and dairy farms (Dolejska et al. 2011), which can be found 
surrounding the Sincil Dike as Lincolnshire contains a large area of farmland. Heavy rainfall can cause 
introduction of agricultural waste to aquatic environments such as rivers and could be responsible 
for the introduction of IncN plasmids at S2 and S3 (Bortolaia et al. 2011; Hammerum et al. 2014). 
IncN plasmids of an animal origin are commonly associated with CTX-M type ESBL genes from 
several groups, a study of CTX-M positive ESBLEC on commercial duck farms revealed presence of 
several CTX-M genes including CTX-M group 1 genes CTX-M-14, -24 and -27, while a study of a dairy 
farm found 39% of ESBLEC samples were positive for CTX-M group 1 enzyme CTX-M-1, the majority 
of which were carried on IncN plasmids, consistent with the 50.0% of the IncN samples detected in 
this study which were positive for CTX-M group 1.  
5.3.3 Effect of WWE on Prevalence of IncP Plasmids & Association with CTX-M Group 1 
 
Inc P was identified in 3 (7.5%) samples and was the least represented incompatibility group tested. 
IncP is less commonly found in the natural environment but has been identified in ESBLEC isolated 
from WWE at similar levels to those identified in this study. No IncP positive samples were found to 
contain CTX-M group 1 genes which is expected as OXA genes, a Class D ESBL enzyme which shows 
hydrolytic activity against oxacillin antibiotics and are commonly found in E. coli, are most commonly 
associated with IncP plasmids (Tennstedt et al. 2003; Schluter et al. 2007). IncP was only detected at 
the site of WWE release suggesting it was introduced by WWE and not a naturally occurring 
incompatibility group in this environment. It was also unable to persist downstream suggesting the 
IncP plasmid was quickly eliminated from its host despite containing 2-3 addiction systems, which 
should ensure its maintenance in host species, however elimination from the small sample may also 
be due to the relatively low number of IncP plasmids present in the environment.  
 
IncP occurred at low frequency, detected in approximately 1 in every 13 samples and therefore may 
have been present upstream at S1 where sample size was significantly smaller. If IncP was in fact 
present upstream and at the point of WWE release but not detected further downstream, it could 
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indicate elimination of the bacterial host by natural selection as they did not contain CTX-M group 1 
genes which appear to provide a selective advantage in this environment.   
 
5.3.4 Occurrence of Multiple Incompatibility Systems  
 
IncP and IncN groups were only detected in samples also positive for IncF in all cases. Data from 
previous study has demonstrated that IncP and IncN can exist alone and in the presence of IncF 
(Carattoli et al. 2005).Two scenarios exist for the possible appearance of multiple incompatibility 
groups in one sample, either a single plasmid belongs to multiple incompatibility groups 
simultaneously, or 2 unique plasmids of different incompatibility groups are able to replicate 
successfully in a single bacterial cell. Plasmids that contain multiple incompatibility groups show an 
increased ability to transfer genetic material by conjugation due to an increased host range, 
however both IncP and IncN were found in relatively low proportions suggesting several unique 
plasmids are responsible. If this is the case, genetic data collected from these samples would be 
representative of several plasmids working in unison as opposed to a single unique plasmid, 
however as they express their genotype together the genetic data collected is still relevant for the 
individual bacterial cell, but may affect results for grouping of plasmid genetic elements. 
5.4 Conclusion 
PCR amplification of 3 incompatibility groups was performed to understand the effect of WWE on 
prevalence of circulating incompatibility groups amongst plasmids of ESBLEC and to determine their 
association with CTX-M group 1. IncF was the most common group detected occurring in 
approximately half of all samples and increased with the introduction of WWE due to an influx of 
ESBLEC containing IncF plasmids, however the percentage of IncF plasmids positive for CTX-M group 
1 decreased. This is potentially a result of the same diversifying effect of WWE addition mentioned 
in chapters 3 and 4, caused by the introduction of ESBLEC carrying IncF plasmids bearing novel ESBL 
genes which proliferate by conjugation and clonal expansion throughout the ESBLEC population.  
 
IncN and IncP were detected infrequently only after the addition of WWE. IncN is commonly 
associated with CTX-M group 1 expression in commercial farm animals but has also been identified 
in some clinical isolates. IncP has been previously been detected in WWE and contained the ESBL 
genes OXA responsible for resistance to oxacillin. It is possible that both IncP and IncN were 
introduced to the environment at S2 by WWE, however IncN plasmids were more likely introduced 
by waste run off from neighbouring farms. This demonstrates the WWE is able to introduce novel 
genetic elements to natural environments to increase genetic diversity, however they may not be 
able to persist further downstream due to lower survivability in the environment compared to native 
organisms. As InP and IncN were detected in less than 1 in every 13 samples at S2 and S3, they may 
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both have been present at S1 but the sample number was too low to be detected. As such IncP and 
IncN may be present throughout the river environment, and were not introduced by WWE. IncN and 
IncP were only detected in samples positive for IncF, similar results have been reported for the co-
existence of IncP, N and IncF groups in a single plasmid. This can also be explained by the presence 
of multiple unique plasmids in a single isolate which would mean genotypic elements detected may 
be describing several plasmids working in unison. The diversification of incompatibility groups and 
CTX-M group 1 genes seen with the addition of WWE in this section supports the idea that WWE 
introduces plasmids with a variety of genetic elements which are able to disseminate by conjugation 
and clonal expansion to diversify ESBLEC genotypes.  
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Chapter 6 – Overall Conclusion  
It has been long understood that the global antibiotic resistance crisis is a significant threat to 
human health with the majority of available antibiotics predicted to be redundant in a few decades. 
Research has mainly focused on the occurrence of resistant organisms in a clinical setting but 
recently has turned to the occurrence and monitoring of antibiotic resistance in the environment. A 
major source of this resistance has been found to originate from treated waste water that contains 
significant levels of resistant organisms following inadequate water treatment which is then released 
back into natural aquatic environments shared by humans and animals alike. In particular, the 
extended spectrum beta-lactamase expressing Enterobacteriaceae family has been implicated in 
clinical infection and found commonly in natural aquatic environments, with the CTX-M gene family 
implicated as the major genetic source of ESBL expression in a number of species. The CTX-M gene 
has rapidly spread globally due to its frequent association with mobile plasmids that are easily 
disseminated through bacterial populations by horizontal gene transfer. WWE release sites have also 
been identified as a major site of plasmid transfer and is speculated to significantly contribute to 
environmental antibiotic resistance. This study confirmed results found in comparative research that 
the addition of WWE to natural aquatic environments measurably increases the number of ESBLEC 
present when compared to the same environment that has not received WWE. Further genetic 
analysis of the plasmids contained within ESBLEC isolated from these environments indicated that 
the increase in resistance is as a result of an increase in the diversity of plasmid genetics as opposed 
to the amplification of plasmid genotypes naturally present in the environment. The introduction of 
WWE saw a shift from few dominant plasmid types to a large number of genetically diverse plasmids 
less likely to contain CTX-M group 1 genes in favour of other undetected ESBL genes, there was also 
a marked decrease in the number of plasmid addiction systems present. The organisms introduced 
by WWE were shown to frequently contain plasmids of an IncF incompatibility group and were less 
commonly associated with CTX-M group 1 genes than their natural counterparts, they were also 
shown to persist further downstream of WWE release and were able to outcompete naturally 
occurring plasmid types in some cases while others were eliminated shortly after their introduction. 
Which plasmids were able to persist and which were eliminated appeared to depend on the 
plasmids ability to transfer horizontally through the population and be maintained with the host cell. 
However, some of the most dominant plasmid types downstream of WWE release contained few of 
the genetic elements associated with stable inheritance and maintenance in favour of CTX-M group 
1 genes which provided increased survivability, suggesting plasmid prevalence is also related to the 
clonal expansion of host cells.  It is clear that WWE release has a dramatic effect on the levels of 
resistance observed in natural aquatic environments which is accompanied by a diversification of 
plasmid genetic elements responsible for expression of this resistance, however it was difficult to 
determine which plasmid genetic elements were the primary cause of plasmid dissemination due to 
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the small nature of this study. In reality it is probably a combination of genetic factors which results 
in plasmid dissemination and spread of antibiotic resistance genes in the environment. A larger scale 
study has been proposed to better understand which factors should be monitored more closely to 
prevent further dissemination.   
 
The diversification of antibiotic genes in the environment is a bad omen for the occurrence of 
antibiotic resistant organisms in clinical practice as these large natural aquatic environments can act 
as reservoirs for ESBLEC, resulting in their return back to clinical environments where they are able 
to cause infection with a poor outcome for the patient.  
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Chapter 7 – Further Study 
This study revealed the significant role WWE addition plays in diversification of ESBLEC plasmid 
genetic elements and the increase in ESBL producing organisms in a single UK river in a small time 
frame. While these results are important in understanding exactly how WWE addition effects our 
natural waterways, the focused nature of the study means the same conclusions may not be 
relevant in all situations where WWE is released into the natural environment. Future study would 
use more effective methods of gene detection and arrangement into genetic plasmid types and use 
a wider data set to truly understand the dynamic relationship between antibiotic resistance in the 
environment and the large scale release on improperly treated WWE. A larger scale study could 
collect a larger number of water samples from more sites up and downstream of WWE at regular 
intervals throughout the year to gain an accurate insight into the changing dynamics of this complex 
environment and the bacteria it contains. 
 A wider range of genetic elements would also be detected, including more addiction systems, 
incompatibility groups and ESBL genes as well as gene families not detected in this study such as 
metal resistance genes. More advanced gene methods would be used, such as sanger sequencing 
and next generation sequencing platforms which allow an entire plasmid genome to be sequenced 
quickly and accurately. This data could then be compared to a database of known plasmid genetic 
elements, revealing not only the specific elements each plasmid contains, but also the genetic 
context in which they are found.  A better understanding of the genetic elements and their context 
contained on these plasmids could potentially reveal which elements are responsible for the 
persistence or elimination of specific plasmid types with the introduction of WWE. Alongside this 
wealth of genetic data, study of antibiotic, heavy metal and disinfectant content of the water 
samples may also reveal the selective pressures placed on organisms at each sample site and aid in 
the understanding of which genes confer increased survivability. 
 This large scale study performed over several years would provide a much deeper insight into the 
microbiome of natural aquatic environments and allow us to ascertain exactly how bacteria 
introduced by WWE interact with native bacteria. This study would be repeated in multiple rivers 
receiving WWE around the country, with the collaboration of other higher education institutes 
located near river environments also receiving WWE, to compare the effect of WWE originating from 
different treatment facilities. Comparison of the treatment methods used in each facility could 
reveal which methods produce cleaner, safer WWE which would be used to reduce the disruption to 
natural microbiomes and prevent dissemination and diversification of ESBLEC plasmid genotypes. 
This could be achieved by collaboration with industry figures such as Anglian water and other local 
water authorities who could provide water samples and details of water treatments process, these 
companies may be willing to help as they have a vested interest in the safety of WWE released into 
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the environment. This would aid in the reform of waste water treatment processes and ensure 
safety of natural aquatic environments around the country. To establish which genetic elements are 
most important in dissemination and persistence of introduced EBLEC plasmid types an in vitro 
model of a river environment would be created with use of a chemostat to maintain a stable 
chemical environment similar to that which occurs naturally. This model could be used to assess 
transfer of a variety of naturally occurring and introduced ESBLEC plasmid types to ascertain which 
are more likely to be transferred horizontally throughout the bacterial population and develop 
strategies to interfere with this transfer. 
Due to the rural nature of the sampling area (Lincoln, UK), some regions in the local area utilise a 
private water treatment facility shared by few households, and in some cases a single family. This 
arrangement can be used as a model to monitor how diet, medical history or current antibiotic 
treatment effects the number and type of ESBLEC plasmid released. This data could then be used to 
determine likely sources of ESBLEC within the population, and develop strategies for minimising 
their accumulation.  
By collecting this information from a wide range of ESBLEC plasmids we can begin to minimise the 
effect of WWE release on the natural environments shared by both humans and animals and 
decrease levels of environmental resistance. Elimination of this environmental resistance reservoir 
could aid in the prevention of clinically significant ESBLEC infection and contribute to the reduction 
of antibiotic resistance globally.  
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Appendix A – Full Table of Results  
  
 
Incompatibility Group Addiction System 
New 
Systematic 
Label 
Location CTX-
M 
Group 
1 
Status 
IncF Inc 
N 
Inc 
P 
Inc 
W 
Inc 
Q 
HokSok ccAB PemK 
1 S1 + - - - - - + + + 
2 S1 + - - - - - + + - 
3 S1 + - - - - - + + + 
4 S1 - - - - - - + - + 
5 S1 + + - - - - + + + 
6 S1 + + - - - - + + + 
7 S1 + - - - - - + + - 
8 S1 + - - - - - + + + 
9 S1 + + - - - - + + + 
10 S1 + + - - - - + + + 
11 S1 + + - - - - + + + 
12 S2 + + - - - - - + - 
13 S2 + - - - - - - + - 
14 S2 + + - - - - - + + 
15 S2 + + - - - - - + + 
16 S2 + - - - - - - - - 
17 S2 + + - - - - - + - 
18 S2 + + + - - - + + + 
19 S3 - - - - - - - + - 
20 S3 - + - - - - + - - 
21 S3 + + - - - - + + + 
22 S3 + - - - - - + + + 
23 S3 - + + - - - - + - 
24 S3 + + - - - - + + + 
25 S3 + + - - - - + - + 
26 S3 - + - - - - - + - 
27 S3 + - - - - - - - - 
28 S3 - + - - - - + - + 
29 S3 - + - - - - + + + 
30 S3 + - - - - - - + - 
31 S3 - + - - - - - + + 
32 S3 + - - - - - - + + 
33 S3 + - - - - - - + + 
34 S3 + + - - - - - + + 
35 S1 - + - - - - - + + 
36 S1 + + - - - - - + - 
37 S2 + - - - - - - + - 
38 S2 + + - - - - + + + 
39 S2 + - - - - - - + + 
40 S2 - + - + - - - + + 
41 S2 + + - - - - + + + 
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42 S2 - - - - - - - + - 
43 S2 + - - - - - - + + 
44 S2 + + - - - - + + + 
45 S2 + + - - - - - + + 
46 S2 + - - - - - - + + 
47 S2 - + - - - - + + + 
48 S2 - + - - - - - + - 
49 S2 + + - - - - + + + 
50 S2 + - - - - - - + - 
51 S2 - + - + - - - + + 
52 S2 - + - - - - + + + 
53 S2 + - - - - - - + + 
54 S2 - + - - - - + + + 
55 S2 - + - + - - + + + 
56 S2 - + - - - - - + + 
57 S2 + - - - - - - + - 
58 S2 - - - - - - - + - 
59 S2 - + - - - - + + + 
60 S2 - + - - - - - + - 
61 S2 + + - - - - + + + 
62 S2 + + - - - - + + + 
63 S2 + - - - - - - + - 
64 S2 + + - - - - + + + 
65 S2 + + - - - - + + + 
66 S2 - + + - - - + + + 
67 S2 - + - - - - + + + 
68 S2 - + - - - - + + - 
69 S2 + - - - - - - - - 
70 S3 + - - - - - - + - 
71 S3 + + - - - - + + + 
72 S3 + + - - - - - + + 
73 S3 + + - - - - + + + 
74 S3 + + - - - - + + - 
75 S3 + + + - - - + + + 
76 S3 + - - - - - - + - 
77 S3 + + - - - - - + + 
78 S3 + + - - - - - + + 
79 S3 - + - - - - + + + 
80 S3 - - - - - - + + + 
81 S3 - - - - - - - + - 
82 S3 - + - - - - + + + 
83 S3 - + - - - - - + + 
84 S3 + + - - - - - + + 
85 S3 - + - - - - + + + 
86 S3 + + - - - - + + + 
87 S3 - - - - - - - + - 
88 S3 + - - - - - - + + 
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